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ABSTRACT 
Active Site Studies of DmpFG, a Bifunctional Aldolase/Dehydrogenase from 
Pseudomonas sp. Strain CF600 
Yu Lei, Ph.D. 
Concordia University, 2008 
DmpFG, a bifunctional aldolase/dehydrogenase (acylating), comprises the last two 
enzymes of the (dimethyl)phenol degradation pathway in Pseudomonas sp. strain CF600. 
DmpG, a class II divalent cation dependent aldolase belonging to the HMGL-like family, 
cleaves 4-hydroxy-2-ketovalerate to pyruvate and acetaldehyde while DmpF, an 
NAD+/CoA dependent aldehyde dehydrogenase (acylating), oxidizes the acetaldehyde to 
acetyl-CoA. 
Studies of the DmpF active site focused on delineation of the coenzyme A binding 
site, and involvement of a conserved cysteine residue, Cysl32, in catalysis and substrate-
mediated inactivation. By coupling hydrogen-deuterium exchange experiments with 
peptic digest/mass spectrometric analysis, coenzyme A was shown to share the same 
binding site as NAD+. Cysl32 was identified as an essential cysteine, and was shown to 
form an acetyl-Cysl32 intermediate which was trapped and identified by mass 
spectrometry. Coenzyme A-mediated inactivation resulted from disulfide bond formation 
between thiol groups of Cysl32 and coenzyme A. Loss of activity in the presence of 
acetaldehyde was incurred by the oxidation of Cysl32 to cysteine sulfinic acid, as 
observed by mass spectrometry. 
Studies of DmpG focused on the roles of metal ions and putative active site residues. 
Purified preparations contained a mixture of Fe, Mn, Zn and Cu, in order of decreasing 
content, with one mol total metal per mol protein. However, this tightly-bound metal 
iii 
could only support residual adolase activity, with full activity requiring high 
concentrations of Mn2+ or Co2+ in the assay, suggesting two classes of metal binding 
sites. Site-directed mutagenesis was carried out on the three ligands to the tightly bound 
metal ion, Aspl8, His200 and His202, as well as another three residues, potentially 
involved in catalysis, Argl7, His21 and Tyr291. D18N, H200A and H202A variants were 
depleted of bound metals, concomitant with complete loss of the residual aldolase 
activity. In the presence of Mn2+ or Co2+, aldolase activities of D18N and H200A variants 
remained very low in comparison with WT, but H202A aldolase activity was comparable 
to WT. Substitutions of Argl7 or His21 significantly impaired aldolase activity, while 
Tyr291 variants had activity similar to WT. Properties of these variants are discussed in 
relation to the family of HMGL-like enzymes. 
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Chapter 1 Introduction 
1 
1.1 General Introduction 
Pseudomonas sp. strain CF600 is able to efficiently decompose phenol, cresols and 
dimethylphenols via the <imp-operon encoded mefa-cleavage pathway (Figure 1.1) (1). 
The last two enzymes in this pathway are DmpF (32.7 kDa) and DmpG (37.3 kDa), 
which form an active heterotetramer (F2G2) (Figure 1.2) (2). They constitute an aldolase 
(DmpG) and an aldehyde dehydrogenase (DmpF) which together convert 4-hydroxy-2-
ketovalerate to pyruvate and acetyl-CoA (Figure 1.3) (7, 2). Previous work indicates (2, 
3) that DmpF and DmpG, are tightly associated, co-purifying and requiring co-expression 
to obtain fully active enzymes. More recently, structural data, summarized below, has 
revealed the intimate details of the association between the subunit components. 
Accordingly, DmpFG is referred to as a bifunctional aldolase/dehydrogenase. 
1.1.1 Overall structure of DmpFG 
The crystal structure of this novel bifunctional enzyme was solved in the presence 
and absence of the cofactor, NAD+ (4). The structure consists of 8 polypeptide chains in 
the asymmetric unit, 4 DmpG and 4 DmpF, arranged as two heterotetramers. The 345-
residue DmpG, which catalyzes the cleavage of 4-hydroxy-2-ketovalerate to pyruvate and 
acetaldehyde, is composed of two domains. At the N-terminus of the structure is a classic 
(a/p)8 TIM barrel domain (residues 1-250) where a metal ion, tentatively assigned as 
Mn2+ (4), is positioned in the active site at the bottom end of the barrel (Figure 1.4). At 
the C-terminus there is an entirely helical structure, called the communication domain 
(residues 251-345), which mediates the interaction with DmpF. DmpF, which converts 
acetaldehyde to acetyl-CoA, is arranged into two domains: the NAD+-binding domain 
(covering residues 1-130 and 286-312) where a typical Rossmann fold provides 
2 
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Figure 1.1 Afe/a-cleavage pathway for phenol degradation in Pseudomonas sp. strain 
CF600. 








Figure 1.2 The structure of biologically active DmpFG - a heterotetramer. 
DmpF complexed with cofactor NAD+; the TIM barrel domain of DmpG contains a 
divalent cation and the product analogue, oxalate (Figure prepared from PDB entry 
1NVM using PyMol). 
4 
DmpG DmpF 
CH COOH Me2+ ft 
HO^^O *5 V ^ H r ^ l
 H 
9 acetaldehvdeN A D N A D H 
4-hydroxy-2-ketovaIerate » acetaldehyde
 + + 
(4H2KV) H 3 C ^ ^COOH CoASH H+ 
pyruvate 
Figure 1.3 DmpFG -catalyzed reaction. 
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Figure 1.4 The (a//3)8 TIM barrel of DmpG. 
The DmpG active site locates at a classic TIM barrel domain which consists of eight 
parallel /3 strands arranged to make up a barrel structure and surrounded by eight a 
helices. Two additional helices, d\ and a'5, are inserted into the barrel motif between /SI 
and a\ and /35 and c6. Inside the barrel a metal ion, tentatively assigned as Mn2+, is 
positioned at the active site at the bottom end of the barrel (Figure prepared using PyMol 
on the basis of PDB entry 1NVM). 
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accommodation for NAD (Figure 1.5), and the dimerization domain (residues 131-285) 
which mediates interaction with DmpG (4). 
1.1.2 Structure and function of DmpG and related HMGL-like family enzymes 
DmpG is a member of the HMGL-like family (where HMGL signifies HMG-CoA 
lyase, another member of the family), which in turn is one of the members of the xylose 
isomerase-like TIM barrel superfamily (5). The HMGL-like family comprises a variety of 
enzymes that catalyze diverse C-C cleavage/condensation reactions, such as 3-hydroxy-3-
methylglutaryl-CoA (HMG-CoA) lyase (EC 4.1.3.4) (6, 7), a-isopropylmalate synthase 
(a-IPMS) (EC 2.3.3.13) (8), 4-hydroxy-2-ketovalerate aldolase (DmpG) (EC 4.1.3.39) (4) 
and transcarboxylase (TC) 5S subunit (EC 2.1.3.1) (9). Active sites of HMGL-like 
proteins locate within a canonical (a/p)s barrel which consists of 8 parallel p-strands 
arranged as a barrel and surrounded by 8 a-helices, each of which brings the chain back 
to one side of the structure for the next strand in the barrel. 
The (a/P)8 barrel of members of the HMGL-like family is highly conserved, with 
similar active site organization in the barrel interior. The active sites of different family 
^ i O-t- 0-4- ~~. 0 j 
members include divalent metal ions such as Mn , Mg , Co or Zn , and they share 
several invariant residues involved in metal coordination and/or enzyme catalysis. 
Although there is still uncertainty about the details of catalysis by enzymes in the 
HMGL-like family, a mechanism which involves general base/acid catalysis and an 
enolate intermediate has been proposed (6). 
7 
Figure 1.5 Rossmann fold of DmpF bound with NAD+. 
The typical Rossmann fold consists of six parallel /3-strands. The nicotinamide ring of the 
bound NAD+ is close (~ 4A) to the proposed active site residue Cysl32 (Figure prepared 
from PDB entry 1NVM using PyMol). 
1.1.2.1 DmpG 
The metal ion in DmpG is coordinated by six ligands in octahedral geometry (4), 
including three residues, Asp 18, His200 and His202, that are conserved in the HMGL-
like family (6-9), as well as two carboxylate oxygens of the product analogue and one 
H2O (Figure 1.6). However, little is known about the roles that the metal ions play in 
either the structure or the catalytic action of DmpFG. 
Although the mechanism of 4-hydroxy-2-ketovalerate cleavage has not previously been 
investigated, one has been proposed on the basis of the crystal structure of DmpFG (4), 
and is summarized in Figure 1.7. His21 and Tyr291 of DmpG (Figure 1.6) were proposed 
to act as general base and acid, respectively, in the reaction. It was also proposed that 
catalysis is correlated with the movement of these two residue side chains to gate the 
entrance of the substrate intermediate channel in the DmpG active site. The histidine 
residue (His21) is positioned where it may act as a base for abstraction of the hydroxy] 
proton of the substrate, 4-hydroxy-2-ketovalerate. Upon carbon-carbon bond cleavage, 
acetaldehyde and enol-pyruvate are produced, leaving His21 protonated. His21 does not 
lie near enough to the enol-pyruvate to facilitate protonation and pyruvate formation, but 
has been proposed to be involved in a proton shuttle using the Tyr291 side chain. The 
Tyr291 sidechain moves so that its hydroxyl group approaches NE2 of the protonated 
histidine side chain and deprotonates it. This movement of Tyr291, which is possible in 
the space present at the active site of DmpG, effectively opens access for acetaldehyde to 
the tunnel between the DmpF and DmpG active sites. When the side chain of Tyr291 
moves back to its original position, it closes off the tunnel and in so doing protonates the 









Figure 1.6 The active site of DmpG in complex with a product analogue, oxalate. 
The divalent cation is coordinated in octahedral geometry: the six ligands include 
Asp 18, His200, His202, one ordered H2O molecule and two carboxylate and 
carbonyl oxygens of the product analogue oxalate, respectively (Figure prepared 
using PyMol based on PDB entry 1NVM). 
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4H2KV Oi^S 




 M e 2 + 








H 3 C Y O 
Figure 1.7 The proposed roles of His21 and Tyr291 in DmpG catalysis and substrate 
intermediate channeling in DmpFG reaction. 
Adapted from reference (4). 
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Arg-17, another conserved residue in HMGL-like proteins, is a candidate for 
stabilizing the oxyanion in the formation of a pyruvate enolate intermediate. Arg-17 is 
also likely to serve as a proton donor which functions as a general acid (10). These 
proposals are based on the structural analysis of product analogue-DmpG (Figure 1.6) 
and product-TC 5S complex (PDB entries 1RQH and 1RQE) (9), as well as the 
investigation of the corresponding Arg in human HMG-CoA lyase (6, 10). 
1.1.2.2 3-Hydroxy-3-methylgIutaryI-CoA lyase 
HMG-CoA lyase, which catalyzes the cleavage of 3-hydroxy-3-methylglutaryl-
CoA into acetyl-CoA and acetoacetate, is a divalent cation-dependent enzyme involved in 
ketone body formation and leucine catabolism (11-13). An EBI SSM (14) search for the 
three dimensional structural alignment of DmpG with all PDB entries shows that HMG-
CoA lyases are the structures most similar to DmpG. With 18.0 % sequence identity, 
DmpG shares the highest homology with HMG-CoA lyase from Brucella melitensis 
(PDB entry 1YDN) in their TIM barrel domains with a 0.44 Q quality score, 1.92 A 
RMSD, a Z score of 9.7 and a P score of 8.7, for 244 Ca alignments. 
Since mutations of HMG-CoA lyase are associated with hereditary HMG-CoA 
lyase deficiency diseases, human HMG-CoA lyase has been quite extensively 
investigated, as have some bacterial forms. General acid/base catalysis is believed to be 
required (7, 75), with a general base removing the proton from the 3-hydroxy group of 
HMG-CoA prior to cleavage of the C2-C3 bond to form acetoacetate and the enol form 
of acetyl-CoA. Acetyl-CoA is released after being protonated on C2 by a general acid 
(Figure 1.8). 
12 




o o Me 
,2+ 
o 
5 V \ , I S 
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» / S' 
acetyl-CoA 
CoA c CoA 
Figure 1.8 Schematic of the proposed mechanism for the reaction catalyzed by 
HMG-CoA lyase. 
Adapted from reference (10). 
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As indicated in Figure 1.8, HMG-CoA lyase activity requires the presence of a 
divalent cation, such as Mg2+, Mn2+ or Ca2+. The metal ion has been proposed to 
coordinate the oxygen atoms of the thioester and hydroxyl groups of HMG-CoA, 
facilitating enolization of the substrate and stabilization of a carbanion intermediate (16). 
Several active site residues which are conserved in HMG-CoA lyases, including some 
metal ion ligands, were identified on the basis of characterization of natural or site-
directed variants, enzyme kinetics, and NMR studies (10, 15, 17-19). The structural 
similarity of HMG-CoA lyase to DmpG, suggests that comparison to the better-
characterized HMG-CoA lyase may provide useful insights into catalysis by DmpG. 
Two histidine and one aspartate residue have recently been shown to ligate a metal ion 
in the crystal structure of HMG-CoA lyase (6, 7). Substitution of His233 of human 
HMG-CoA lyase, the first histidine of the HXH metal-binding motif, with Arg, Ala, or 
Asp diminished activity by 104-fold in comparison with WT lyase. The Km values of the 
variants for both substrate, HMG-CoA, and divalent cation were comparable to the values 
measured for WT, supporting assignment to His233 of a catalytic role (18). Variants of 
His235, the second histidine in the HXH metal binding motif, exhibited 15-fold reduced 
catalytic activity and a Km for substrate increased 4-fold compared with WT. The 
interaction of enzyme with divalent cation was completely destroyed, indicating that 
His235 is essential for ligating the metal ion (17). HMG-CoA lyase deficiency can result 
from mutations at Asp42, which is the conserved aspartate residue involved in metal 
binding by HMGL-like family proteins. Substitutions that eliminated a carboxyl group at 
Asp42 perturbed metal ion binding and substantially lowered catalytic efficiency, but did 
14 
not impair substrate binding. Such observations support assignment of Asp42 to roles in 
catalysis and metal ion binding (19). 
Active site cysteine and arginine residues have been implicated in catalysis by HMG-
CoA lyase. The significant diminution in catalytic efficiency of Cys266 variants, which 
display no apparent structural perturbations, is consistent with an active site assignment, 
possibly as a general base catalyst (15). Inspection of the structures of human and 
bacterial enzymes indicated that this conserved Cys is located on a flexible loop whose 
position may change upon substrate binding to bring the Cys into close enough proximity 
to participate in general base catalysis (6, 7). There is no comparable Cys residue in 
DmpG. Arg-41, which corresponds to Arg-17 of DmpG and is also highly conserved in 
the HMGL-like family, is the best-studied active site residue in HMG-CoA lyase. The 
variant R41Q is associated with human HMG-CoA lyase deficiency. The R41Q and 
R41M variants exhibited 10 -fold and 10 -fold decreases in activity, respectively, and 
based on Mn + binding and affinity labeling stoichiometry, no structural perturbation was 
observed. Together, these results are consistent with a role for Arg-41 in catalysis. 
Acetyldithio-CoA, an analogue of the reaction product, acetyl-CoA, was used to further 
probe the function of Arg-41: proton exchange NMR data suggest it is involved in 
deprotonation or enolization of acetyldithio-CoA, implicating this residue in the HMG-
CoA cleavage reaction chemistry that leads to acetyl-CoA product formation (10). 
1.1.2.3 a-Isopropylmalate synthase 
a-Isopropylmalate synthase (a-IPMS), which catalyzes acetyl group transfer from 
acetyl-CoA to a-ketoisovalerate to produce a-isopropylmalate (a-IPM ) and CoA, is the 
first enzyme in the leucine biosynthetic pathway. The crystal structure of a-IPMS from 
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Mycobacterium tuberculosis, in complex with Zn and its substrate, a-ketoisovalerate, 
was solved recently (PDB entry 1SR9) (8). The enzyme is dimeric and each monomer 
encompasses an (a/p)g TIM barrel domain, a helical linker domain, and a regulatory 
domain of novel fold. When the three-dimensional structure of DmpG was aligned with 
that of M. tuberculosis a-IPMS using the EBI SSM program, 16 % sequence identity and 
2.09 A RMSD were observed over a Ca alignment of 240 residues, together with a Q 
quality score of 0,2 and a Z score of 9.4. The TIM barrel domains of DmpG (sequence 
10-249) and a-IPMS (sequence 73-332) matched extremely closely. Furthermore, three 
residues, Asp-81, His-285 and His-287 of a-IPMS, which are involved in octahedral 
coordination to Zn2+, are aligned with the metal ligands Asp-18, His-200 and His- 202 of 
DmpG, respectively. Similar to DmpG, the Zn ion of a-IPM synthase is observed in the 
crystal structure to interact with two carbonyl oxygens of the substrate, a-ketoisovalerate. 
1.1.2.4 Transcarboxylase 5S subunit 
Transcarboxylase (TC) (EC 2.2.3.1) is a multienzyme complex made up of three 
different subunits, 12S, 5S and 1.3S, which together transfer a carboxyl group from 
methylmalonyl-CoA to pyruvate via two carboxylation half-reactions to form 
oxaloacetate and propionyl-CoA. The 5S subunit of TC catalyzes oxalacetate production 
by shuttling the carboxyl group from the 1.3S-carboxylated-biotin to pyruvate in the 
second half reaction. Six 5S structures from Propionibacterium shermanii have been 
published (9), and show significant structural similarity with DmpG at the active site. 
The catalytically active Co2+ locates at the C-terminal of the (a/P)s TIM barrel 
octahedrally coordinated with Asp-23, His-215, His-217, one H2O molecule and two 
carboxylate oxygen atoms of oxaloacetate, the substrate for the back-reaction (PDB 
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entry 1RQE). These are the metal ligands that are conserved in the other HMGL-like 
family members. 
1.1.2.5 Metal ion involvement in HMGL-like family enzymes and class II aldolases 
As discussed above, all HMGL-like family members include a conserved Asp-
His-His triad that is observed to coordinate a metal ion in the x-ray structure. In some 
cases, the metal ion is observed in crystals obtained from solutions without added metal 
ion (4, 9), while for others crystals were obtained from solutions supplemented with 
metal salts (6-8). 
Other types of evidence are consistent with a requirement for more than a single 
metal in catalysis. HMG-CoA lyase from Pseudomonas mevalonii was isolated with 
tightly-bound Cu2+ and while addition of Mn2+ (micromolar) or Mg2+ (millimolar) to the 
assay buffer was essential to activate the enzyme, Cu2+ or Zn2+ addition had no effect on 
enzyme activity (20). However, for either human or bacterial HMG-CoA lyases 
crystallized from solutions containing either Mg2+ or Ca2+, respectively, only one metal 
atom was visualized in the active site ligated to the Asp-His-His motif (6, 7). A divalent 
cation was observed in the crystal structure of a-IPM synthase from Mycobacterium 
tuberculosis (8), and has been linked by kinetics studies to catalysis, but a monovalent 
cation must also be present for optimal activity (21, 22). In transcarboxylase 5S from 
Propionibacterium shermanii, one mol of the protein contained two mol of a mixture of 
Co, Zn and Cu atoms, but only Co2+ and Zn2+, rather than Cu2+, could stimulate the 
enzyme activity (23). In the x-ray structure of the enzyme, only a single bound metal ion 
was observed at the conserved active site Asp-His-His metal-binding motif typical of the 
HMGL-like family (9). Although these types of evidence suggest involvement of more 
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than a single metal ion at the active sites of these enzymes, binding characteristics and 
roles in catalysis of the second metal ion have not been delineated. 
The relatively well-characterized class II fructose-1, 6-bisphosphate aldolases 
(FBPA) from lower organisms are unrelated to DmpG, although like DmpG they are 
divalent cation-dependent aldolases which catalyze C-C bond cleavage or condensation 
within (a/p)8 barrel catalytic domains. A divalent cation is an absolute requirement for 
class II FBPA activity and stability (24, 25), and monovalent cation (e.g. K+) is also 
required to activate these enzymes [e.g. (24)]. Various divalent cations, such as Zn , 
Co , Fe , Mn and Ni , could restore the activity of yeast apo-aldolase to different 
degrees: Zn2+ was found in the native enzyme in the highest amount and was the optimal 
activator (24). Structural studies of FBPA have revealed binding sites for more than a 
single divalent cation, although the divalent cation involved in catalysis is ligated to three 
His residues in all available FBPA structures (25-29). During catalysis, the Zn + in E. coli 
FBPA is thought to function as a Lewis acid to polarize the carbonyl bond of the 
substrate, dihydroxyacetone phosphate (25). The other metal ion binding sites identified 
in several FBPA structures, either for divalent or monovalent cations, are not all identical 
to one another and may include both specific and non-specific metal binding sites (25-
29). The monovalent cation binding site in E. coli FBPA is clearly defined and has, on 
the basis of its position in a complex of enzyme with substrate analogue, been proposed 
to be involved in tethering substrate at the active site (25). 
Characterization of DmpG will add to our understanding of the roles of the metal ion 
in catalytic activity and structural stability, as well as the mechanism of the enzymes in 
the HMGL-like family. 
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1.1.3 Structure and function of DmpF and related enzymes 
DmpF is an NAD+- and CoA-dependent acetaldehyde dehydrogenase which 
catalyzes oxidation to acetyl-CoA of the intermediate acetaldehyde generated by DmpG. 
Acetaldehyde is likely to be highly toxic to the cell (30-32). It has been proposed that this 
intermediate is channeled via a 29 A long connecting hydrophobic tunnel from the active 
site of DmpG to that of DmpF where it is converted to the non-toxic and metabolically 
useful final product, acetyl-CoA (4). 
The proposed DmpF active site is positioned between the NAD+ binding domain and 
the dimerization domain. The nicotinamide ring of NAD+, which must accept a hydride 
from acetaldehyde, is close to a cysteine residue, Cysl32, which was proposed to be an 
essential catalytic residue (Figure 1.9) (3, 4). Cysteine residues become more reactive 
when they are deprotonated, and in the aldehyde dehydrogenase literature there is 
considerable discussion about the structural basis for active site thiol activation (33-41). 
In the apo (ligand-free) structure of DmpF, a water molecule is positioned within H-
bonding distance of Cysl32 and also within H-bonding distance of an aspartate residue, 
Asp209. Interestingly, the water molecule is not present in the holo (NAD+-bound) 
structure and the cysteine side chain adopts two conformations, one similar to that in the 
apo enzyme and one where the thiol group is pointing towards the cofactor, suggesting 
that it may function in water mediated proton abstraction from Cysl32 (4). Thus, it was 
proposed that in the absence of the cofactor, Cysl32 is first activated by Asp209 via a 
water molecule: this facilitates binding of NAD+, the presence of which also accelerates 
the DmpG reaction. 
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Aldehyde dehydrogenases comprise a superfamily in which members may be 
classified into two families on the basis of cofactor dependence: the NAD(P)+-
dependent, CoA-independent enzymes and the NAD(P)+- and CoA-dependent family. 
Two subfamilies are included in the former group of enzymes. One subfamily consists of 
phosphorylating NAD(P)+-dependent aldehyde dehydrogenases, which reversibly oxidize 
the aldehyde substrate to a phosphoester with the participation of inorganic phosphate 
(42-44). The other subfamily includes the non-phosphorylating NAD(P)+-dependent 
aldehyde dehydrogenases, which irreversibly oxidize the aldehyde substrate to the 
corresponding acid (33, 45). Both CoA-dependent and phosphorylating NAD(P)+-
dependent aldehyde dehydrogenases follow ping-pong reaction mechanisms during 
catalysis, where NAD(P)H is released prior to the binding of the last substrate (inorganic 
phosphate or coenzyme A). By contrast, non-phosphorylating NAD(P)+-dependent 
aldehyde dehydrogenases follow an ordered sequential kinetic mechanism with 
NAD(P)H dissociating last (34, 46). 
In spite of the different kinetic mechanisms, both phosphorylating (42, 43) and non-
phosphorylating NAD(P) -dependent aldehyde dehydrogenases (33, 45) share a similar 
two-step chemical reaction which involves the acylation and deacylation of a conserved 
cysteine residue in the active site of the enzyme (Figure 1.10). In the first step, the 
activated cysteine thiolate group nucleophilically attacks the carbonyl carbon of substrate 
aldehyde to form a thiohemiacetal enzyme complex. This is followed by hydride transfer 
to NAD(P)+, resulting in a covalent acylenzyme intermediate. Finally, the acyl group is 
displaced by an inorganic phosphate, or hydroxyl group from water, via a nucleophilic 
reaction to form a phosphoester or an organic acid product, respectively. 
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Figure 1.9 The proposed active site of DmpF in complex with the cofactor, NAD+. 
The Asp209 residue of DmpF is located where it may act as a general base for activation 
of the essential Cysl32 via an H20 molecule (not shown) during the DmpF reaction 
(Figure prepared using PyMol on the basis of PDB entry 1NVM). 
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Figure 1.10 Proposed catalytic mechanism of NAD(P)+-dependent, CoA-independent 
aldehyde dehydrogenase. 
See text for a description. 
22 
The architectures of a thiohemiacetal complex and an acylenzyme intermediate were 
characterized in two recently-solved crystal structures of aspartate-P-semialdehyde 
dehydrogenase, which is a representative of the phosphorylating NAD(P)+-dependent 
aldehyde dehydrogenases (35, 47). The structure of the thioacylenzyme intermediate of 
the E268A-glyceraldehyde 3-phosphate dehydrogenase from Streptococcus mutans 
provides similar insights into the catalytic mechanism of the non-phosphorylating 
NAD(P)+-dependent aldehyde dehydrogenases (36). The acylation and deacylation 
mechanisms for phosphorylating and non-phosphorylating NAD(P)+-dependent aldehyde 
dehydrogenase appear to be different. The phosphorylating NAD(P)+-dependent enzymes 
have been proposed to involve a catalytic triad in activation of the essential active site 
cysteine (35, 37, 38). There is still discussion about the detailed catalytic mechanism for 
the non-phosphorylating NAD(P)+-dependent ALDHs (33, 34, 36, 39-41). The idea that 
the activation of the essential cysteine is induced by the protein environment has been 
proposed (39, 41). 
The NAD(P)+-and CoA-dependent aldehyde dehydrogenase subfamily, which 
includes DmpF, is one of the classes that has not been well characterized in the aldehyde 
dehydrogenase extended family. Most of the studies in the literature have focused on the 
kinetics of a few of these enzymes (48-54). As is the case for the phosphorylating 
NAD(P)+-dependent aldehyde dehydrogenases, the NAD(P)+- and CoA-dependent 
enzymes have also been postulated to catalyze reactions involving covalent acyl-S-
enzyme intermediates (48, 49, 52, 54). However, the existence of such acylenzyme 
intermediates has not been reported in the literature. Interestingly, CoA-mediated 
inhibition has been observed and shown to involve the formation of a dead-end E-CoA 
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inhibition complex (52). 
Details of the structure and function of the NAD(P)+- and CoA-dependent 
aldehyde dehydrogenase enzymes are still far from being understood. Characterization of 
DmpF will not only provide insight into the cofactors' binding sites, catalytic mechanism, 
and the substrate-mediated inhibition of this enzyme and of its relatives, but also help to 
address substrate intermediate acetaldehyde channeling and regulation of DmpF in 
complex with DmpG. 
1.1.4 Substrate Intermediate Channeling of DmpFG 
Channeling of intermediates in enzyme reactions involves movement of reaction 
intermediates between distant active sites within a multi-step enzymatic transformation 
(55, 56). Specifically, the intermediate is passed to the next active site without prior 
dissociation into the bulk solvent by free diffusion. Intermediate substrate channeling has 
many advantages over the free diffusion of reaction intermediates within the bulk cellular 
environment. First, it prevents the loss of intermediates by diffusion and speeds up the 
rate of the overall enzymatic reaction since the path taken by the intermediate is more 
direct. Second, it avoids unfavorable equilibria and kinetics that may occur within the 
cellular environment. In particular, competing enzymatic or non-enzymatic 
transformations within the cell can be avoided by maintaining the intermediate in a 
sequestered milieu. Third, an intermediate that is toxic or unstable that is channeled 
provides a mechanism whereby the cell and the intermediate can be protected. Fourth, 
since the highly dense nature of the cell cytoplasm results in very scarce solvation 
capacity, sequestering the intermediate from the cellular environment can conserve this 
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solvation capacity. Finally, channeling decreases the unfavorable energetics associated 
with desolvation of the intermediate. 
Various data are consistent with the existence of a channelling mechanism for 
transferring acetaldehyde between DmpG and DmpF active sites. For example, the two 
proteins are physically associated with one another to form the biological active 
heterotetramer (F2G2) (7, 2). Furthermore, the aldolase reaction is significantly enhanced 
in the presence of a cofactor, NAD+, which is likely bound to the dehydrogenase active 
site (2). More directly, the crystal structure of DmpFG indicates the presence of a 29A 
hydrophobic channel extending from the DmpG active site towards the active site of 
DmpF upon the binding of cofactor NAD+ (4). Thus, the structure of this complex would 
support transport or channeling of the toxic acetaldehyde intermediate from the active site 
of DmpG, where it is generated, to DmpF, where it is converted to acetyl-CoA. In the 
absence of the NAD+ cofactor this tunnel does not extend all the way to the active site of 
DmpF, suggesting that binding of NAD+ at the active site of DmpF is essential to control 
the movement of the intermediate between distant active sites by inducing domain 
movement of DmpF. This may facilitate the DmpF active site's ability to accept the 
intermediate and has been proposed to be crucial for efficient channeling (4). 
1.2 Thesis Objectives 
DmpFG, a bifunctional enzyme, has both a divalent cation-dependent class II aldolase 
(DmpG) activity and an NAD+/CoA-dependent acetaldehyde dehydrogenase (DmpF) 
activity (2). This enzyme is involved in the bacterial degradation of phenol and methyl-
substituted phenols, and its many homologues are found in bacterial catabolic pathways 
for degradation of other aromatics, such as naphthalene, salicylate, toluene and biphenyl 
25 
(57). Relatively little has been reported on the characteristics of DmpFG, or related 
enzymes in aromatic catabolism, so learning more about how they function will fill a gap 
in our knowledge of the enzymology of these pathways. In addition, studies of these 
enzymes will lead to improved understanding of how microbes accomplish the task of 
degrading relatively inert and often toxic aromatic compounds. 
DmpG belongs to the newly-identified HMGL-like family, members of which 
share similar active site structures inside an (a/p)g TIM barrel fold: these enzymes 
catalyze diverse C-C bond cleavage reactions and are believed to employ a common 
catalytic reaction mechanism (58). However, we are still far from a complete 
understanding their catalytic mechanisms, with unresolved questions such as existence of 
enolate intermediates during the reaction, and the identities of residues involved in 
catalysis (6). Crystal structures of DmpFG and a complex of DmpFG with substrate 
analogue have suggested residues that could be targeted for site-directed mutagenesis (4) 
to help address such questions, contributing to the broader picture of the whole HMGL-
like family. 
A second topic, about which little is currently known, is me function of the bound 
metal ion in DmpG and other HMGL-like family members. Different divalent metal ions 
show varying ability to activate these enzymes and active site variants, while others, 
including some that activate other aldolases, have no effect on activity, or even inhibit. 
Although a metal ion is observed in the crystal structure of DmpG and other HMGL-like 
family members, it is not currently known how much it contributes to catalysis, enzyme 
stability, or even whether it is the only metal ion that binds at the active site. Based on 
what is already known about DmpFG and a survey of the literature of HMGL-like family 
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proteins (6-9, 59, 60), as well as class II fructose-1, 6-bisphosphate aldolases (FBPA) (24, 
25, 61, 62), the bound metal ion in DmpG may function to stabilize the DmpFG complex, 
participate in substrate binding and/or contribute to DmpG catalysis. Site-directed 
mutagenesis, enzyme kinetics and ICP-MS techniques are combined here to investigate 
these possible functions. 
Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating, GAPDH), is the 
best-characterized structurally similar aldehyde dehydrogenase to DmpF (37, 38, 42, 43, 
63, 64) . Thus, it provides an instructive model for probing DmpF catalytic mechanism, 
despite the fact that GAPDH is not CoA dependent. In general, the NAD+/CoA-
dependent aldehyde dehydrogenases have not previously been subjected to structural and 
structure-function studies, with literature about them mostly limited to few detailed 
steady-state kinetics studies (49, 51, 52). In this thesis, the binding site of the coenzyme 
A cofactor is investigated by coupling hydrogen-deuterium exchange with mass 
spectrometric analysis after proteolysis. Aspects of the catalytic mechanism of DmpF are 
studied, such as kinetics, site-directed mutagenesis of Cysl32, formation of acetyl-
Cysl32 intermediate enzyme complex, and reaction ot Cysl32 with substrate-derived 
inhibitors. The characterization of DmpF adds to our knowledge of a relatively poorly-
understood subfamily of the aldehyde dehydrogenase superfamily. 
Several lines of evidence suggest that the tight association of DmpG and DmpF is to 
allow acetaldehyde channeling from the aldolase active site to the dehydrogenase active 
site without free diffusion via the bulk solution (3, 4). However, the functional 
significance of the tunnel architecture and its regulation remain unexamined. Channeling 
has been unequivocally demonstrated in relatively few enzymes (65-69), so future studies 
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of channeling in DmpFG will increase our knowledge in this area. The work done here 
on catalytic properties of the two active sites is a useful and necessary prelude to 
channeling studies in the future. 
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This chapter was reprinted with permission from Biochemistry 2008, 47, 6870-6882. 
Copyright 2008 American Chemical Society. 
Chapter 2 A Shared Binding Site for NAD+ and Coenzyme A in an Acetaldehyde 
Dehydrogenase Involved in Bacterial Degradation of Aromatic Compounds 
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2.1 Abstract 
The meta-cleavage pathway for catechol is a central pathway for the bacterial 
dissimilation of a wide variety of aromatic compounds, including phenols, 
methylphenols, naphthalenes, and biphenyls. The last enzyme of the pathway is a 
bifunctional aldolase/dehydrogenase that converts 4-hydroxy-2-ketovalerate to pyruvate 
and acetyl-CoA via acetaldehyde. The structure of the NAD+/CoASH-dependent 
aldehyde dehydrogenase subunit is similar to that of glyceraldehyde-3-phosphate 
dehydrogenase, with a Rossmann fold-based NAD+ binding site observed in the 
NAD+-enzyme complex [Manjasetty, B. A., et al. (2003) Proc. Natl. Acad. Sci. U.S.A, 
100, 6992-6997]. However, the location of the CoASH binding site was not determined. 
In this study, hydrogen-deuterium exchange experiments, coupled with peptic digest and 
mass spectrometry, were used to examine cofactor binding. The pattern of 
hydrogen-deuterium exchange in the presence of CoASH was almost identical to that 
observed with NAD+, consistent with the two cofactors sharing a binding site. This is 
further supported by the observations that either CoASH or NAD+ is able to elute the 
enzyme from an NAD+ affinity column and that preincubation of enzyme with NAD+ 
protects against inactivation by CoASH. Consistent with these data, models of the 
CoASH complex generated using AUTODOCK showed that the docked conformation of 
CoASH can fully occupy the cavity containing the enzyme active site, superimposing 
with the NAD+ cofactor observed in the X-ray crystal structure. Although CoASH 
binding Rossmann folds have been described previously, this is the first reported example 




Aldehyde dehydrogenases make up a diverse group of enzymes that are present in a 
wide variety of organisms including mammals, plants, bacteria, and fungi. These 
enzymes may be categorized on the basis of cofactor dependence: (i) NAD(P)+-
independent aldehyde dehydrogenases such as EC 1.2.99.3 and EC 1.2.7.5, which are 
found in some bacteria (70, 71); (ii) NAD(P)+-dependent aldehyde dehydrogenases such 
as EC 1.2.1.3 and related enzymes, which have been isolated from both prokaryotes and 
eukaryotes (72-74); and (iii) CoASH/NAD(P)+-dependent aldehyde dehydrogenases such 
as EC 1.2.1.10 and EC 1.2.1.27 , which are mainly associated with a few species of 
bacteria (48-54, 75-77). While NAD(P)+-dependent members of the aldehyde 
dehydrogenase (ALDH) extended family have been well characterized (72-74), 
CoASH/NAD(P) -dependent aldehyde dehydrogenases have received much less 
attention. 
The literature on CoASH/NAD(P)+-dependent aldehyde dehydrogenases focuses 
mainly on the steady-state kinetics and some other properties of a few individual 
members (48-54, 77). For example, a relatively well-characterized coenzyme A-linked 
aldehyde dehydrogenase from Clostridium kluyveri (52) catalyzes the transformation of 
acetaldehyde to acetyl-CoA accompanied by NAD+ reduction with a pH optimum of 9.1. 
On the basis of initial velocity and product inhibition experiments, a ping-pong 
mechanism was proposed. Thus, NAD+ and acetaldehyde bind first, NADH is released 
prior to CoASH binding, and then the final product, acetyl-CoA, is released. Formation 
of an acetyl-enzyme intermediate during the reaction was postulated. Interestingly, 
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inhibition by CoASH was also reported, and the formation of a dead-end E-CoASH 
inhibition complex was demonstrated (52). 
DmpF (EC 1.2.1.10) is the only CoASH/NAD(P)+-dependent aldehyde 
dehydrogenase for which a high-resolution structure has been published. DmpF and 
DmpG form an active heterotetramer (F2G2) which catalyzes the last two reactions in the 
meta-cleavage pathway of phenol degradation in Pseudomonas sp. strain CF600 (2). 
DmpG (EC 4.1.3.39) is a type II aldolase that converts 4-hydroxy-2-ketovalerate to 
acetaldehyde and pyruvate, while DmpF catalyzes the transformation of acetaldehyde to 
acetyl-Co A using NAD+ and CoASH. The X-ray structure of DmpFG (4) shows eight 
polypeptide chains in the asymmetric unit: four DmpGs (A, C, E, and G) and four DmpFs 
(B, D, F, and H) that form two heterotetramers each with a molecular mass of 280 kDa. 
DmpF comprises two domains, including the NAD binding domain (residues 1-130 and 
286-312), and the dimerization domain (residues 131-285) which mediates the 
interaction with DmpG. 
The NAD -binding domain of DmpF is similar to that of glyceraldehyde-3-
phosphate dehydrogenase (phosphorylating) (4). Sequence analysis using the Pfam 
database (78) shows that the NAD+ -binding domain belongs to the NADP_Rossmann 
clan and most closely resembles the family Semialdhyde_dh with an E value of 
1.4 x 10"24: the structure of aspartate semialdehyde dehydrogenase, also a 
phosphorylating enzyme, has an NAD+ binding fold similar to that of glyceraldehyde-3-
phosphate dehydrogenase (79). By contrast, another CoASH/NAD(P)+-dependent 
enzyme, methylmalonate semialdehyde dehydrogenase (EC 1.2.1.27), is instead 
structurally related to the large superfamily of nonphosphorylating aldehyde 
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dehydrogenases and is the only member which is CoASH-dependent (74, 77, 80). As 
discussed below, DmpF, like glyceraldehyde-3-phosphate dehydrogenase 
(phosphorylating), binds NAD+ via a canonical Rossmann fold. By contrast, 
nonphosphorylating aldehyde dehydrogenases exhibit noncanonical Rossmann folds for 
NAD+ binding (33, 80-82). Thus, CoASH-dependent aldehyde dehydrogenases 
belonging to the two families may bind CoASH differently. However, no structure has 
yet been published for a member of either class in complex with CoASH. 
Two glycine-rich motifs that are characteristic of nucleotide binding domains are 
found in DmpF: GnXGXXGi6 is located between the loop following the first p strand 
and the adjacent a helix of the Rossmann fold, and G165XGXXA170 in the loop adjacent 
to a8, in the a9 helix and in its following loop, which are located in the dimerization 
domain (Figure 2.1). The NAD+-binding Rossmann fold consists of one each of (Pa)3 and 
(c<p)3 units in which the (P«)3 unit (residues 5-65) is mainly involved in AMP moiety 
binding and the (ap)3 unit (residues 67-128) is mainly responsible for NMN moiety 
binding (Figure 2.2): these units are connected via the a3 and a4 helices. Like 
glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) and aspartate 
semialdehyde dehydrogenase, the dimerization domain of DmpF is also involved in 
NAD+ binding, mainly via the NMN moiety. The AMP portion of bound NAD+ is closest 
to the outside environment, while the NMN portion is located in the interior of the protein 
and encompassed by both NAD+ binding and dimerization domains. 
The conformation of NAD+ when bound to DmpF is very similar to the conformation 
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Figure 2.1 Secondary structural elements of DmpF. 
Residues shaded dark grey highlight p strands, while residues shaded light gray highlight 
a-helical regions (derived from PDB entry 1NVM). 
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Figure 2.2 Structural overview of the NAD+-DmpF complex. 
61 -B6 represents the six-stranded parallel sheet that comprises the typical Rossman fold 
mainly involved in AMP binding; ct8 and al2 are mainly responsible for the NMN 
binding together with other structural elements (derived from PDB entry 1NVM). 
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observed in complex with glyceraldehyde-3-phosphate dehydrogenase from Bacillus 
stearothermophilus (PDB entry 1GD1) (4, 83). Thus, both the adenine and nicotinamide 
rings are in anti conformations and approximately perpendicular to the adjacent ribose 
rings. The two ribose ring planes are perpendicular to each other. The AMP portion is 
more elongated than the NMN portion, and both moieties are on the same side relative to 
the phosphates. The NMN moiety is in the proximity of the rest of the molecule, so it is 
only half the distance from the nicotinamide group to the closest phosphate as it is in 
bound NAD+ on other enzymes such as horse liver alcohol dehydrogenase (PDB entry 
20HX) (84). 
Although a structure of the NAD+-DmpF complex has been obtained using X-ray 
crystallography, the mode of binding of coenzyme A has not been defined. In this study, 
we have used hydrogen-deuterium exchange experiments to probe the binding of CoASH 
and have found that this cofactor shares the same binding site as NAD+. 
2.3 Experimental Procedures 
Bacterial Strains and Plasmids of Escherichia coli. XL2-Blue was used for DNA and 
plasmid amplification, and proteins were expressed in E. coli C41(DE3) (85). DNA 
manipulations were performed using standard protocols (86). A subclone of pVI150, 
pVI1316A (1), was digested with Xholl to generate a 3757 bp fragment that was 
subsequently ligated into the Bamlil site of the pT7.5 expression vector (87). Orientation 
was checked by restriction enzyme digestion. The dmpFG coding region was thus 
inserted downstream from the T7 promoter, to give plasmid construct pT7.5-dmpFG. 
Bacterial Growth. The pT7.5-dmpFG plasmid (10 ng) was transformed into E. coli 
C41(DE3) competent cells by incubating the mixture on ice for 15-20 min. Cells (50 uX) 
36 
were then spread onto LB agar plates to grow overnight at 37 °C using carbenicillin 
selection (100 ug/mL). LB medium (10 mL) was added to each plate to suspend the 
colonies. After transfer of the suspended cells into 1 L of fresh LB medium containing 
ampicillin (100 ug/mL), cells were grown for ~ 2 h until the OD600 reached 0.8-1, at 
which point IPTG (1 mM) was added to induce protein overexpression. Cells were 
allowed to grow for an additional 3 h before being harvested. After being washed with 50 
mM Na+ K+ phosphate buffer (pH 7.5), cell pellets were stored at -80 °C until they were 
used. 
Preparation of Affinity Resin. A^-carboxymethyl-NAD+ was synthesized essentially as 
described by Tynan et al. (88). An excess of iV6-carboxymethyl-NAD+ was coupled at 
4 °C to EAH-Sepharose (GE Healthcare) using l-ethyl-3-[3-
(dimethylamino)propyl]carbodiimide, essentially as described by the manufacturer except 
that pH was maintained between 4.5 and 5.5 by the addition of HC1, as described in 
reference (88). After incubation overnight, the resin was washed thoroughly using 
several alternating aliquots of 0.1 M sodium acetate (pH 4), containing 0.5 M NaCl, and 
0.1 M Tris-HCl (pH 8), containing 0.5 M NaCl. A final wash of 20% ethanol was 
applied. 
Protein Purification. Compared to the previously published method (2), the steps for 
purifying DmpFG were simplified to DEAE and NAD+-linked affinity columns, 
combined with an ammonium sulfate fractionation step. The buffer used for purification 
was 50 mM Na+ K+ phosphate (pH 7.5) containing 1 mM DTT (PD buffer) unless 
otherwise specified, and all the purification steps were carried out at 4 °C. Approximately 
25 g of cell paste from 6 L of culture was resuspended in -50 mL of PD buffer, and a 
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spatula tip of DNase I was added. Cell suspensions in a salt/ice bath were sonicated in 30 
mL batches with a Branson model Sonifier 250 at an output setting of 60 for 10 x 25 s. 
The cell debris was removed by ultracentrifugation for 1 h at 62000g. The clear 
supernatant, termed crude extract, was carefully transferred to a 100 mL cylinder and 
then applied to a Fast-Flow DEAE-Sepharose column (36.5 cm x 2.6 cm) equilibrated 
with PD buffer. After the sample had been loaded, the column was washed with PD 
buffer (100 mL) and then with PD buffer containing 50 mM NaCl (200 mL) at a flow rate 
of 6 mL/min. A linear gradient of 0.05 to 0.275 M NaCl in PD buffer (750 mL/750 mL) 
was applied at the rate of 6 mL/min. Fractions (12 mL) were collected, and those with 
high CoASH-dependent acetaldehyde dehydrogenase specific activity were combined. 
DmpFG was precipitated with 55% saturated ammonium sulfate and then kept in an ice 
bath for least 30 min before being collected by centrifugation. The protein precipitate was 
dissolved in PD buffer to a total volume of 5 mL. After being desalted with a PD-10 
column, the protein was applied to an NAD+ affinity column (3.3 cm x 1.7 cm). The 
column was washed with 25 mL of PD buffer and then eluted using 0.1 M NaCl in PD 
buffer. Fractions (2 mL) were collected, and those with high dehydrogenase specific 
activity were combined. The sample was exchanged with 50 mM Na K phosphate (pH 
7.5) containing 0.5 mM TCEP-HC1 two to five times and then finally concentrated to ~2 
mL. This operation was performed by ultrafiltration using an Amicon concentrator 
equipped with a YM-30 membrane. The concentrated protein was aliquotted into 
microfuge tubes (20-50 uL/tube) and then stored at -80 °C. The activity was stable for at 
least 6 months (2). 
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Deuterium Exchange Experiments. Deuterium exchange experiments essentially followed 
previously published methods {89-91). The pH measurements were performed with an 
Orion Micro-Combination pH/Sodium Electrode 98-10. All pH values of D20-
containing buffers reported here were corrected using the equation pH= pD + 0.3139* + 
0.0854x2 (92) , where pD is the pH meter reading of the buffer and x is the fraction of 
deuterium. Three different samples were equilibrated at 25 °C for 1 h: (1) 22 pL of 
DmpFG protein [8.53 mg/mL, 121.8 uM, in 50 mM Na+ K+ phosphate buffer ( pH 7.5) 
containing 0.5 mM TCEP-HC1] with 5.5 pL of 50 mM Na+ K+ phosphate buffer (pH 7.5) 
containing 0.5 mM TCEP-HC1; (2) 22 uL of DmpFG protein with 5.5 pL of 10.1 mM 
NAD+ in 50 mM Na+ K+ phosphate buffer (pH 7.5) containing 0.5 mM TCEP-HC1; and 
(3) 22 pL of DmpFG protein with 5.5 pL of 11.5 mM CoASH in 50 mM Na+ K+ 
phosphate buffer (pH 7.5) containing 0.5 mM TCEP-HC1. 
The H-D exchanges were initiated by transferring the equilibrated samples with 
multichannel pipettors to aliquots (192.5 uL) of 50 mM Na+ K+ phosphate D2O buffer 
(pH 7), 25 °C, without cofactors, with NAD+ (2.05 mM), or with CoASH (2.3 mM). 
These reaction mixtures were contained in 250 uL thin-walled PCR tubes inserted in a 
metal heat block kept in a 25 °C water bath. The H-D exchange reactions were thus 
carried out at 25 °C, at pH 7.09, and with 87.5% D20 buffer. At various time points, 20 
pi of each of the three different samples was transferred to mixtures in PCR tubes 
containing 110 uL of 0.12% TFA and pellet from 80 uL of immobilized pepsin slurry (on 
cross-linked 6% agarose beads, 2-3 mg/mL of gel, purchased from Pierce Chemical Co.). 
Mixing with TFA resulted in a pH of 2.56, effectively quenching the exchange, with the 
PCR tubes kept at 0 °C by insertion in a metal block which was incubated in an ice/salt 
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water bath. The immobilized pepsin had been prepared by being washed six times with 
0.05% TFA (pH 2.41), and in separate experiments monitored using SDS-PAGE it was 
established that the pellet from 80 uL of the immobilized pepsin slurry was sufficient to 
digest completely the DmpFG protein in these samples (data not shown). To facilitate 
digestion efficiency, up-and-down operation of a multiple-channel pipettor was used to 
mix the protein and the immobilized pepsin. After 5 min, the digested samples were 
separated from immobilized pepsin by centrifugation in a microfuge at top speed for 40 s; 
the supernatants were then aliquoted into thin-wall PCR tubes and frozen in liquid 
nitrogen. The frozen samples were stored at -80 °C prior to mass spectrometry analysis. 
In- and Back-Exchange Controls for Deuterium Incorporation. The extent of deuterium 
incorporation into each peptic peptide must be adjusted for deuterium gain and loss 
during quench, peptic digestion, and mass spectrometric analysis. The amount of 
deuterium lost and gained from a partially deuterated peptide may be estimated from the 
amount of deuterium lost from a completely exchanged peptide ("back-exchange" or 
"100% control") and gained from a unexchanged peptide ("in-exchange" or "0% 
control"), respectively. The in- and back-exchange control experiments were carried out 
according to methods described previously (91, 93). The in-exchange control (0% 
control) was performed by addition of 2 uL of DmpFG protein to the 0 °C mixture of 110 
uL of 0.12% TFA and a pellet from 80 uL of immobilized pepsin slurry, 0.5 uL of 50 
mM Na+ K+ phosphate H20 buffer (pH 7.5), and 17.5 uL of 50 mM Na+ K+ phosphate 
D2O buffer (pH 7). The digestion and associated procedures were the same as those in the 
deuterium exchange experiments reported above. The back-exchange control (100% 
control) was started by dissolving the peptic digest of DmpFG dried from the 
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unexchanged control sample (prepared as described below) in 2.5 uL of H2O and 17.5 uL 
of D2O, producing a mixture containing concentrations of peptides, buffer, and deuterium 
corresponding to those of the H-D exchange experiments. Samples were then incubated 
at 25 °C for 2 h to ensure 100% deuterium replacement of the amide hydrogens in the 
peptides derived from the intact protein. After addition of 110 uL of 0.12% TFA at 0 °C, 
samples were incubated at 0 °C for the same time period required for sample quenching 
to pepsin bead isolation, as in the deuterium exchange experiments. 
Measurements of Protected Amide Hydrogens, Incorporated Deuterons and Their 
Exchange Rate Constants for Peptic Digests ofDmpFG. The matrix used in the MALDI 
experiments was a-cyano-4-hydroxycinnamic acid (5 mg/mL) in acetonitrile/99% 
ethanol/0.07% TFA mixture (1:1:1) (pH 2.5). The matrix solution was kept at 0 °C before 
use. Frozen sample digests were thawed rapidly, and 10 u.1 was mixed with an equal 
volume of matrix; 0.7 uL of the mixture was spotted onto the chilled target plate. The 
sample spots were dried with a stream of nitrogen gas over ~ 1 min. The spotted and 
dried target plate was transferred as quickly as possible to the mass spectrometer. The 
spectra were collected using a Micromass M@LDI-LR TOF mass spectrometer. Spectra 
were obtained for both deuterium-exchanged samples and unexchanged controls in which 
the sample was prepared under identical conditions except that buffer prepared with H20 
was substituted for D20-containing buffer: these samples were used for sequencing 
peptides using ESI-Q-TOF MS/MS (details below). 
By comparing the spectra of exchanged samples with those of unexchanged controls, 
we identified the peptides with deuterium incorporation. When masses of peptides from 
H-D experiments with cofactors shifted at least 0.5 Da lower relative to those incubated 
41 
without cofactors, peptides were considered to have undergone amide hydrogen 
protection by cofactor binding. The number of amide hydrogens protected was estimated 
by comparing mass differences of the H-D exchange peptides from incubations with and 
without cofactor. The number of deuterons incorporated into peptic digest peptides of 
DmpFG was calculated using the equation D = (mt- w?o%) x «/(/wioo% - «o%), where D is 
the adjusted number of deuteriums incorporated at time point t; mh mo%and mioo% are the 
observed masses of a peptide at time point t, time zero (0% control), and fully exchanged 
(100% control), respectively, and n is the total number of peptide amide hydrogens. The 
rate constants for deuterium exchange were obtained by fitting the data to a double 
exponential model using SigmaPlot 9.0 with the equation D = TVi(l-e'V) + A^l-e'V), 
where D is the total number of incorporated deuterons at time t, and N] and N2 are the 
numbers of deuterons exchanging at rate constants k\ and k2, respectively. A mixture of 
six standards, bradykinin (1060.569 amu), angiotensin I (1296.687 amu), Substance-P 
(1347.736 amu), Glu-fibrino peptide (1570.677 amu), renin (1758.933 amu) and ACTH 
(18-39clip, 2465.199 amu), was used to calibrate the instrument. Internal lockmass 
corrections using ACTH (18-39clip, 2465.199 amu) were used to improve the mass 
accuracy. 
Identification of the Peptic Digests of DmpFG. Using the unexchanged control sample, 
accurate masses of peptic digests of DmpFG were calculated on the basis of m/z data of 
ESI-Q-TOF spectra. The peptides were preliminarily identified on the basis of accurate 
masses by searching DmpFG sequence data with the ExPASy-FindPept tool (94). 
Typically, several possible peptides of DmpFG were indistinguishable since insufficient 
mass accuracy was obtained in the ESI-Q-TOF measurement, and therefore, peptide 
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sequencing was carried out using a Waters CapLC system interfaced with an ESI-Q-TOF 
2 mass spectrometer. Peptic digests of DmpFG (5 uL) were loaded onto a Symmetry 300 
CI8 trap column (0.35 mm x 5 mm), for desalting and concentration, followed by elution 
onto an Atlantis dC CI8 NanoEase column, (75 urn x 100 mm). Mobile phase A 
consisted of formic acid (0.1%) and acetonitrile (3%), while mobile phase B consisted of 
formic acid (0.1%) and acetonitrile (97%). The CapLC system was equilibrated with a 
mixture of 95% solvent A and 5% solvent B. The samples were loaded and desalted for 6 
min in the trap column (20 uL/min) with the equilibration solvent. Then the flow was 
switched to the separating column, and a gradient from 5 to 50% mobile phase B was run 
(6 uL/min) over 50 min, followed by 5 min with 50% B, and then an increase to 95% B 
over 10 min. After the survey scan had been performed, MS/MS was performed online as 
peptides eluted from the column, selecting individual peptide precursors: the collision-
induced dissociation (CID) energy used for fragmentation was between 25 and 48 eV 
depending on the mass and charge state of the precursor ion. The peptides picked for 
MS/MS were mainly those with double and triple charges, and a few with quadruple and 
quintuple charges. 
The raw data from MS/MS of peptic digests of DmpFG were first processed using 
MaxEnt3 and then loaded into the peptide sequencing program of the BioLynx module of 
MassLynx version 4.0. The sequence predictions were finally obtained by performing the 
automated MassSeq approach which often gave a partial sequence of the peptide. A 
combination of accurate mass and partial sequencing information resulted in the final 
assignments for peptic digests of DmpFG {95). The Q-TOF 2 instrument calibration was 
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achieved via MS/MS of human [Glu ]-fibrinopeptide B (1569.6698 Da). The voltage on 
the capillary probe tip was set to 3.3 kV, and the voltage on the sample cone was 43 V. 
Enzyme Kinetic Experiments. Acetaldehyde dehydrogenase activity was monitored by the 
reduction of NAD at 340 nm in the presence of acetaldehyde and CoASH. 
The apparent Km values for NAD+ and CoASH were estimated from initial rate 
measurement in 50 mM HEPES buffer (pH 8.0) containing 1 mM DTT at 25 °C. The 
reactions were started by addition of DmpFG protein (0.75 ug/mL) to the assay mixture 
containing substrates NAD+, CoASH, and 38.4 mM acetaldehyde. 
The examination of the effects of coenzyme A on DmpF was performed at pH 7, 
in 50 mM Na+ K+ phosphate buffer at 25 °C. The DmpFG sample was buffer-exchanged 
with 50 mM Na+ K+ phosphate buffer (pH 7), and TCEP-HC1 was removed prior to 
further experiments. The assay mixtures contained 3.0 ug/mL of DmpFG protein, 75.1 
uM CoASH 15.5 mM acetaldehyde, and various concentrations of NAD+. To examine 
interactions of CoASH with DmpF, the following experiments were performed. The 
standard assay to which others were compared was initiated by addition of enzyme as the 
last component of the assay mixture. To test possible inhibition by CoASH, the enzyme 
was incubated with CoASH before addition of other components, and the reaction was 
initiated by addition of acetaldehyde. To examine whether NAD+ could protect against 
inhibition by CoASH, the enzyme was incubated with NAD+ prior to CoASH, and then 
the reaction was started by addition of acetaldehyde. The effects of DTT were tested 
using the same procedure as the CoASH inhibition assay except that the HEPES buffer 
already contained 1 mM DTT. Recovery of activity from the CoA-inhibited enzyme by 
the addition of DTT was examined using the same assay procedure that was used for 
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CoASH inhibition except that 0.1 M DTT was added to the assay mixture after the 
incubation of enzyme with CoASH (final DTT concentration of 1 mM). 
Automated Docking of CoASH to DmpF. The three-dimensional coordinates for the entire 
molecule of CoASH (coaclean.pdb) were obtained from the HIC-Up Server 
(http://xray.bmc.uu.se/hicup). Atomic coordinates corresponding to the nucleotide 
portion of CoASH were initially superimposed onto those of the NAD+ cofactor found in 
the DmpFG structure (PDB entry 1NVM) using the program LSQMAN (96). The atomic 
coordinates of CoASH corresponding to the pantetheine portion of the cofactor were 
manually adjusted by general bond torsions using O (97) such that all atoms resided 
within a cavity consisting of the DmpF active site and a tunnel connecting the active site 
to the protein surface. This model was selected as the candidate ligand for automated 
docking to DmpF using AUTODOCK (98). Eight of the 20 possible torsions in CoASH 
were active in the docking simulation. The grid of the docking simulation was defined by 
a21 A x 21 A x 2 1 A cube centered on the CoASH molecule within the DmpF active 
site. The docking simulation was performed using a Lamarckian genetic algorithm search 
routine with a population of 50 individuals and a maximum of 500000 energy 
evaluations. In total, 291 generations were analyzed. Molecular graphics were generated 
using PyMOL (99). 
2.4 Results 
Hydrogen—Deuterium Exchange Experiments. To characterize the binding of NAD and 
coenzyme A to DmpFG, hydrogen-deuterium exchange experiments were performed by 
mixing small volumes of DmpFG protein, DmpFG-NAD+ complex or DmpFG-CoASH 
complex, with large volumes of D20-containing buffer. Cofactor binding sites would be 
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expected to become inaccessible to D20 as a result of shielding by any bound cofactors. 
Comparison of the mass spectra of peptides from pepsin digests of holo-DmpFG to those 
of apo-DmpFG following quenching at pH 2.5 and 0 °C allowed identification of sites 
where accessibility to solvent changed upon cofactor binding. In the NAD+ or CoASH 
binding experiments, 2 mM NAD+ or 2.3 mM CoASH permitted observation of 
reasonable MALDI MS signals. These concentrations also appeared to be saturating, 
since no significant increase in the number of amide hydrogens protected was observed 
with 4 mM NAD+ or CoASH (data not shown). H-D exchange experiments were also 
performed with either NAD+(0.5 and 1 mM) or CoASH, and the same peptides exhibited 
amide hydrogen protection against H-D exchange although the number of incorporated 
deuteriums increased (data not shown). Since the accessibility changes were the same at 
these different concentrations of cofactors, a single binding event was likely measured in 
these experiments. 
To identify the pepsin-generated fragments of DmpFG obtained after quenching, we 
sequenced peptides using HPLC-ESI-Q-TOF MS/MS. A total of 86 peptides were 
observed, and 79 were identified (Figure 2.3). Seven peptides could not be characterized 
because of the weak signal and the interference from strong adjacent peaks. Among the 
79 identified peptides, 42 were from DmpF, covering 89% of the sequence (Figure 2.3A) 
and 37 were from DmpG, covering 85% of the sequence (Figure 2.3B). Fewer identified 
peptides were observed in the MALDI-TOF spectra: 26 peptides from DmpF were 
observed, covering 69% of the sequence (Figure 2.3A), and 23 observed DmpG peptides 
accounted for 66% of the sequence of DmpG (Figure 2.3B). In the in- and back-exchange 















 VRVDRE TLGLGYAGVYSSFLRHAE IAAAKYNXiKTLDILVELGHRRMVGGQEDMIV 
331 DVALDLLAAHKENRA 
Figure 2.3 Identification of peptides from pepsin digests of DmpFG. 
(A) Peptides from DmpF identified using MS/MS are underlined and cover 89% of the 
sequence; fragments observed in the MALDI-TOF spectrum only are underlined in gray, 
and cover 69% of the sequence. (B) Peptides from DmpG identified using MS/MS are 
underlined and cover 85%) of the sequence; fragments observed in the MALDI-TOF 
spectrum only are underlined in gray and cover 66%> of the sequence. 
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back-exchanges were observed among the fragments showing amide hydrogen protection 
against H-D exchange. 
From H-D exchange data, various numbers of amide hydrogens in peptides 
corresponding to DmpF residues 9-19, 36-63, 46-63, 155-174, 275-291, and 275-301 
were found to be involved in protection against H-D exchange in the presence of cofactor 
(Table 2.1). Incorporation of deuteron into these fragments was biphasic and almost 
reached the maximum after 10 min (Figure 2.4). Table 2.1 (columns 2 and 3) summarizes 
the total number of amide hydrogens protected at 15 min, determined directly from the 
mass shifts of the peptides at this time point. In addition, fitted deuterium incorporation 
rate constants and amplitudes from kinetics experiments such as those shown in Figure 
2.4 are also given in Table 2.1 (columns 4-6). The limited number of data points that 
could be collected in the early time period means that the fitted rate constants for the 
faster reaction represent only a lower limit. Nevertheless, the rates and amplitudes of 
deuterium incorporation in the presence and absence of CoASH and NAD+, as well as the 
difference in the total number of deuterons exchanged in the presence and absence of 
each cofactor, are useful probes of their binding sites. 
The rates of hydrogen-deuterium exchange in the presence of CoASH, as well as the 
numbers of protons exchanged, were, with a few exceptions, indistinguishable from those 
observed with NAD+, suggesting that the two cofactors share a single binding site. 
Furthermore, for all fragments, the number of protons exchanging in the slow phase was 
relatively constant regardless of the presence or absence of coenzyme, while the number 
exchanging in the fast phase was significantly decreased in the presence of either NAD+ 
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Table 2.1 H-D Exchange Parameters of Peptides of DmpF with Amide Hydrogen 


















observed total no. 
of amide H atoms 
protected against 
H-D exchange 
binding at 15 min 
NAD+ 
3.2 + 0.3 
3.1+0.1 
3.0 + 0.1 
4.2 + 0.1 






4.2 + 0.2 
1.0 ± 0.1 
4.2 ±0.2 
no. of exchanged amide H atoms 
[rate constant (min*1)] for fast and slow phases* 
no cofactor 
4.1 +0.1(10.6 ±3.6) 
2.3 ±0.1(0.3 ±0.1) 
9.7 ±0.3 (9.0 ±3.0) 
4.4 ±0.2 (0.4 ±0.1) 
-
12.6 + 0.5 (6.1 ±2.1) 
5.9 ±0.3 (0.3 ±0.1) 
-
7.8 ±0.3 (5.5 ±1.6) 
7.8 ±0.3 (0.4 ±0.1) 
NAD+ 
1.7 ± 0.1 (7.4 + 2.1) 
1.5 ±0.1 (0.4 ±0.1) 
8.3 ±0.4 (7.6 ±2.5) 
2.7 ±0.2 (0.4 ±0.2) 
-
8.8 ±0.4 (5.7 ± 1.8) 
5.4 ±0.2 (0.3 ±0.1) 
-
4.5 ±0.2 (4.3+ 1.1) 
6.9 ± 0.2 (0.3 ± 0.2) 
CoASH 
1.5 ±0.1 (7.2 ±2.6) 
1.8 ±0.1 (0.4 ±0.2) 
9.0 ±0.2 (7.6 ±3.0) 
3.1 ±0.2 (0.4 ±0.2) 
-
9.0 ±0.5 (5.7 ± 1.7) 
5.4 ±0.2 (0.3 ±0.1) 
-
4.4 ±0.3 (4.3+ 1.7) 
7.2 ±0.4 (0.3 ±0.1) 
Data shown are averages for three independent experiments. 
* From fitting of deuterium exchange data to double exponential as shown in Figure 2.4 
and as described in Experimental Procedures. 
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Figure 2.4 Isotopic envelopes of peptides at 10 min (left) and kinetics of incorporation of 
deuterium into DmpF-derived peptides (right). 
Each isotopic envelope indicates peptides from an enzyme that was (a) complexed with 
CoASH, (b) complexed with NAD+, and (c) without cofactor binding. Kinetics plots are 
each fit to a double-exponential equation, as described in Experimental Procedures, with 
rate constants and amplitudes as in Table 2.1: (A) 1058.57Da peptide (residues 9-19), 
(B) 1972.03Da peptide (residues 155-174), (C) 2778.40Da peptide (residues 36-63), and 
(D) 2761.37Da peptide (residues 275-301). 
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or CoASH. This implies that the more readily accessible backbone protons are blocked 
by cofactor binding, as one might expect. 
Affinity Chromatography and Inhibition by CoASH. Several other experimental 
observations support the notion that CoASH and NAD+ share a single cofactor binding 
site. Thus, either CoASH or NAD+ was able to elute the enzyme from an NAD+ affinity 
column (Table 2.2). Furthermore, preincubation of the enzyme with NAD+ protected 
against inhibition by CoASH: inhibition was reversed by the addition of DTT, as one 
would expect if CoASH inhibition involves a covalent adduct with the enzyme via a 
disulfide bond at the active site (Figure 2.5). Since DmpF, like other CoASH-linked 
acetaldehyde dehydrogenases (48, 52) catalyzes a ping-pong reaction (Chapter 3) in 
which NAD+ and acetaldehyde bind and NADH is released prior to CoASH binding, 
occupation of the same binding site by the two cofactors is feasible. 
Comparison ofH—D Exchange Results with NAD+-DmpF Crystal Structure. Patterns of 
protection against hydrogen-deuterium exchange in the presence of NAD+ are consistent 
with the reported crystal structure of the DmpF-NAD+ complex (4). This structure 
indicates that the peptide corresponding to DmpF residues 9-19 contains the 
dinucleotide-associated binding motif, GXGXXG (residues 11-16) involved in binding to 
the pyrophosphate, adenine, and ribose ring moieties of NAD+ (4): in the presence of 
NAD+, three amide hydrogens were protected against H-D exchange (Figure 2.4A, traces 
b and c, and Table 2.1). The peptide corresponding to DmpF residues 155-174, includes 
a similar GXGXXA motif (sequence 165-170), and mediates binding to pyrophosphate, 
the nicotinamide and its ribose rings; for this peptide, three amide hydrogens were 
protected from H-D exchange upon NAD+ binding (Figure 2.4B, traces b and c, and 
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Table 2.2 Effectiveness of NAD+, CoASH, or NaCl in Eluting Native DmpFG Bound to 
an NAD+ Affinity Column 
apparent Km 
for NAD+ (uM) 
156 
apparent Km 
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• — DTT recovery 
•»— CoA inhibition 
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[NAD+] (mM) 
Figure 2.5 Inhibition by preincubation with CoASH and protection by NAD+ and DTT. 
Assay conditions are as described in Experimental Procedures. 
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Table 2.1). Peptides corresponding to DmpF residues 36-63 (overlapping with fragment 
46-63) and 275-301 (overlapping with 275-291) are involved in binding to the adenine 
and nicotinamide rings, respectively: in the presence of NAD+, four amide hydrogens 
were protected against deuterium replacement for each peptide (Figure 2.4C, traces b and 
c, and Figure 2.4D, traces b and c, and Table 2.1). 
Comparison ofH-D Exchange Results with NAD+ and CoASH. Very similar patterns of 
protection against H-D exchange were observed in the DmpF subunit upon CoASH 
binding. Thus, peptides corresponding to DmpF residues 9-19, 155-174, 36-63, 46-63, 
275-291 and 275-301 all exhibited amide hydrogen protection against H-D exchange in 
the presence of either CoASH or NAD+. Furthermore, in peptides corresponding to 
DmpF residues 9-19, 36-63 and 275-301 the same total number of hydrogens were 
protected against exchange as in NAD+ binding (Figure 2.4A, C, D, traces a and c, 
respectively, and Table 2.1). However, only two amide hydrogens of the peptide 
corresponding to DmpF residues 155-174 were protected against deuterium replacement 
upon CoASH binding (Figure 2.4B, traces a and c, and Table 2.1). Significantly, no 
differences in H-D exchange upon cofactor binding were observed in the DmpG subunit 
(data not shown). 
These results strongly suggest that the mode of CoASH binding to DmpF is very 
similar to that of NAD+, reported for the X-ray structure. The nucleoside moiety of 
CoASH could interact with regions of peptides corresponding to DmpF residues 9-19, 
155-174 and 36-63, all of which interact with the ADP moiety of NAD+ (Figure 2.6). 
The segment of DmpF corresponding to residues 275-301 is likely to be associated with 
the binding of the pantetheine chain, which would need to approach Cysl32 in the DmpF 
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active site in preparation for nucleophilic attack on acetyl-S-Cysl32, a postulated 
intermediate (4). Further insight into the interaction of CoASH with DmpF was obtained 
by modeling it using AUTODOCK. 
Computer-Aided Modelling of the CoASH-DmpF Complex. Of the 50 conformers 
generated by AUTODOCK, 22 conformers organized into 14 clusters were obtained that 
exhibited energetically favorable binding to DmpF (energy of docking < -13 kcal/mol; 
rmsd compared to reference CoASH < 2.0 A). One of the clusters (cluster 6) contained 
three CoASH conformers (6_1, 6_2, and 6_3) in which the thiol group is proximal to the 
thiol group of DmpF Cysl32 "B" conformation. The thiol group of conformer 6_1 was 
observed to be within 2.65 A of the B thiol group of Cysl32. The other two CoASH 
conformers within this cluster had thiol-thiol distances to the Cysl32 B thiol of 2.79 and 
3.65 A, respectively. The 6_1 conformer was estimated by AUTODOCK to bind to 
DmpF with a AG of-11.3 kcal/mol and with a predicted dissociation constant of 5.04 x 
10"9 M. Its rmsd compared to the input CoASH reference coordinates was calculated by 
AUTODOCK to be 1.64 A. The binding of CoASH conformer 6 1 to DmpF is shown in 
Figure 2.7A. Extensive hydrogen bonding occurs between the pyrophosphate moiety of 
the 6_1 conformer and DmpF backbone amide groups. Two hydrogen bonds were 
observed between the 4'-phosphate of the docked CoASH and DmpF residue Serl2: one 
to the hydroxyl group of the side chain and one to the backbone carbonyl group of the 
residue. The 4'-phosphate is further stabilized by hydrogen bonding between its 04 atom 
and the backbone amide groups of Asnl4 and Ilel5. 
Beyond the potential disulfide formation with CoASH at DmpF Cysl32, hydrophilic 
interactions between the pantetheine moiety of CoASH conformer 6_1 and DmpF are not 
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Figure 2.6 Comparison of NAD+and coenzyme A structures. 
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extensive. No hydrogen bonds are observed between the protein and the pantetheine 
carbonyl groups. A molecular surface projected onto DmpF indicates that the docked 
conformation of CoASH conformer 6 1 fully occupies the cavity containing the enzyme 
active site and superimposes with the NAD+ cofactor observed in the X-ray crystal 
structure of the holoenzyme (Figure 2.7B). 
2.5 Discussion 
Our hydrogen-deuterium exchange data establish that CoASH and NAD+ share a 
cofactor binding site in the DmpF subunit of DmpFG. The changes in H-D exchange in 
the presence of the cofactor are consistent with the crystal structure of the enzyme-NAD+ 
complex (4), and the model of the enzyme-CoASH complex derived here. 
The observation that a single Rossmann fold can alternately bind nicotinamide 
cofactor and coenzyme A appears to be unique. NAD(P) -binding Rossmann folds have 
been characterized in many different dehydrogenases (100), and Rossmann folds that 
bind coenzyme A have also been characterized {101); to the best of our knowledge, a 
single Rossmann fold that binds both cofactors has not been described previously. 
Interestingly, the sequence of DmpF clusters in the Pfam database with the NAD+-
binding Rossmann fold of phosphorylating dehydrogenases such as aspartate 
semialdehyde dehydrogenase (79), rather than the CoASH-binding fold of succinyl-CoA 
synthetase (101). Furthermore, a three-dimensional structure-based search of the PDB 
archive using Secondary Structure Matching (SSM) (14) revealed the closest match to 
structures of glyceraldehyde-3-phosphate dehydrogenases, rather that CoA-binding 
Rossmann fold-based proteins (data not shown). Nevertheless, the NAD+ and CoA-
binding Rossmann folds are quite similar to one another (100). 
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Figure 2.7 Models generated using AUTODOCK. 
(A) Binding of CoASH docked conformer 6 1 to DmpF. The CoASH cofactor is shown 
as sticks and colored according to element (blue for nitrogen, orange for phosphate, red 
for oxygen, white for carbon, and yellow for sulfur). The DmpF protein is shown in a 
cartoon representation (flat coils: helices). DmpF residues protected against H-D 
exchange are shaded as follows: residues 9-19, light orange; residues 36-63, green; 
residues 155-174, yellow; and residues 275-301, pink. The remaining DmpF residues are 
colored light blue. The two conformations of the Cysl32 side chain are shown as sticks 
(white for carbon and yellow for sulfur). The residue Serl2, colored by elements, is also 
shown. (B) Superposition of CoASH conformer 6 1 with NAD+ in the DmpF active site. 
A molecular surface, colored light blue, generated on DmpF shows the extent of the 
cavity containing the DmpF active site. The rest of the DmpF protein is shown in cartoon 
representation as in Figure 2.7A. Docked CoASH conformer 6 1 is shown as sticks 
(colored as in Figure 2.7A). The NAD+ cofactor found in the crystal structure of the 
holoenzyme (PDB entry 1NVM) is shown as sticks and is colored light pink. These 
models were generated using Pymol. 
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Cofactor Binding Site Characterization. In DmpF, the observation that three amide 
hydrogens of the fragment of residues 9-19 were protected by NAD+ against deuterium 
replacement (Table 2.1) is in agreement with the crystal structure data. The A03* oxygen 
atom of the adenine ribose of NAD+ forms a hydrogen bond to the main chain nitrogen 
atom and the side chain hydroxyl oxygen atom of Serl2. The main chain nitrogens of 
Asnl4 and lie 15 bind to the pyrophosphate through hydrogen bond interaction with A02 
and N02 oxygen atoms, respectively. Meanwhile, the side chain of He 15 and the 
nicotinamide ring of NAD+ are involved in a van der Waals interaction. 
Homologous interactions are observed in the modeled complex with CoASH. The 
03 atom of the adenine ribose of CoASH H-bonds with the main chain nitrogen of 
Glyl3 instead of that of Serl2 in the NAD+-DmpF complex, while the main chain 
nitrogens of Asnl4 and Ilel5 hydrogen bond to 04 of CoASH. Furthermore, the side 
chain of He 15 interacts with CI2 of the pantetheine chain of CoASH, in place of the 
nicotinamide ring of NAD+. The observation that three amide hydrogens in this region 
were protected against H-D exchange upon CoASH binding is thus consistent with the 
AUTODOCK model, although it should be noted that protection from H-D exchange 
need not necessarily correlate with the number of amide hydrogen bonds. 
When NAD+ and CoASH bind, three amide hydrogens and two amide hydrogens, 
respectively, of a peptide corresponding to DmpF residues 155-174 were protected from 
H-D exchange (Table 2.1). Two amide hydrogens may be protected by the hydrogen 
bonding interaction between the amide nitrogens of Glyl65 and Glyl67 and the 
pyrophosphate oxygen of NAD+ (N01 and A01) (4) or CoASH (05 and 01) in the 
modeled complex. The origin of the extra amide protected against exchange by NAD+ 
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may be the H-bonding interactions between the side chain nitrogen and carbonyl oxygen 
of Asnl71 and N03* and N02* of the nicotinamide ribose. In the modeled CoASH 
complex, the side chain nitrogen and carbonyl oxygen of Asnl71 appear to be involved 
in weaker van der Waals contacts with C6 and C7 of the pantetheine chain. 
The labeling patterns of overlapping DmpF peptides corresponding to residues 
46-63 and 36-63 indicate that within the shorter peptide (residues 46-63), three amide 
hydrogens are protected from H-D exchange, while in the longer peptide one additional 
proton is protected (Table 2.1). While crystal structure data show that three residues, 
Val36, Gly37, and Ile38, within the DmpF sequence of residues 36-45 are involved in 
van der Waals interactions with NAD+, no residue within the sequence of residues 46-63 
is in direct contact with bound NAD+. In this case, the observed protection against H-D 
exchange may result from protein conformational change that makes some amino acid 
residues less accessible and other residues more exposed to the solvent. In fact, a 
significant conformational change was observed upon cofactor binding to DmpFG in the 
crystal structure (4), as summarized in Figure 2.8A. The structural differences observed 
upon NAD+ binding affect not only residues which directly interact with cofactor but also 
other regions which are located near the binding site or even farther from it (Figure 
2.8B). Residues in positions 36-45 undergo a large movement upon NAD+ binding, 
especially Asp39 and Ala40: these residues could not be matched with the corresponding 
residues in the apo structure. Residues 46-63 also shift considerably such that Thr54, 
Thr55, Thr56, and Tyr57 in the apo and holo structures do not overlap (Figure 2.8B). 
Thus, protection of the three amide hydrogens observed in the peptide corresponding to 
DmpF residues 46-63 is likely due to the conformational change caused by NAD+ 
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binding. Essentially identical H-D exchange behavior in peptides corresponding to 
DmpF residues 46-63 and 36-63 was observed upon CoASH binding (Table 2.1), in 
which three amide hydrogens were protected in the shorter peptide (residues 46-63), and 
one additional proton was protected in the longer peptide, suggesting that CoASH 
stimulates a conformational change in DmpF similar to that which occurs when NAD+ 
binds. 
Comparison of another pair of overlapping peptides, corresponding to DmpF 
residues 275-291 and 275-301, indicates that one and four amide hydrogens are 
protected upon NAD+ binding, respectively (Table 2.1). In the DmpFG crystal structure, 
the side chain amide nitrogen of Asn290 contacts the carboxamide nitrogen of the bound 
NAD+. One side chain carbon of Leu291 contacts the carboxamide oxygen of NAD+, 
and the side chain CG and CE atoms of Met 294 interact with NC5 and NC6 in the 
nicotinamide ring. In addition, alignment of the holo and apo structures indicates that 
residues 285-294 undergo a large displacement upon NAD+ binding (Figure 2.8B). We 
propose that protection of the four amide hydrogens in the peptide corresponding to 
residues 275-301 is due to the direct interaction of three residues, Asn290, Leu291, and 
Met 294, with the nicotinamide ring or to the conformational change associated with 
NAD+ binding. The same H-D exchange events were observed in peptides corresponding 
to residues 275-291 and 275-301 upon CoASH binding as observed upon NAD+ 
binding. The fact that no interaction occurred between residues 275-301 and CoASH in 
the model of the complex supports our hypothesis that protection of the four amide 
hydrogens is likely due to a conformational change similar to that observed upon NAD+ 
binding. 
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In the crystal structure of DmpFG, Cysl32 of DmpF is 3.4 A from the 
nicotinamide ring of NAD+. The covalent modification of an enzyme-based thiol group 
by CoASH, suggested by the results shown in Figure 2.5, could be explained by the close 
approach of the thiol group of bound CoASH to the thiol group of Cysl32. In the 
CoASH-DmpF model, the 2.65 A distance between the sulfur atom of Cysl32 and the 
thiol group of CoASH is, given a reasonable degree of error in the model, potentially 
short enough for formation of a disulfide bond. Interestingly, the atoms at the end of the 
pantetheine chain, including atoms SI, C2, C3, N4, C5, and 05 of the carbonyl oxygen, 
are all proximal to atoms of Cysl32, Thrl31, or Vall30 residues, which may help 
position the thiol group, allowing it to form the disulfide bond. Although formation of a 
disulfide bond appears to occur when CoASH is incubated with enzyme in the absence of 
other substrates, a close approach of the CoASH thiol would also be required for attack 
on a Cysl32-thioacetyl intermediate in the proposed catalytic cycle (4). 
Comparison with Other CoASH-Binding Proteins. More 100 structures of CoASH-
binding proteins in complex with the cofactor have been determined. The CoASH-
binding folds for these proteins include a large variety of different topologies. Some folds 
are not exclusive to CoASH binding (the four-helical up-and-down bundle, the Rossmann 
fold, and the TIM barrel fold) while others have been reported in only CoASH-binding 
proteins to date (702). Only succinyl-CoA synthetase {101, 103), formyl-CoA transferase 
from Oxalobacter formigenes (104) and, a protein of unknown function, Pfu-723267-001 
from Pyrococcus furiosus (PDB ID entry 1Y81), have been shown to bind CoASH at a 
Rossmann fold, which appears to be the case with DmpF. However, none of these 
proteins has been reported to bind NAD(P)+ also. The identification of structural features 
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Figure 2.8 Comparison of DmpF (apo) and DmpF-NAD+ (holo) structures based on 
PDB entry 1NVM. 
(A) Superimposition of Holo-DmpF (chain H, dark gray) and apo-DmpF (chain F, light 
gray) backbones. Active site residue Cysl32 is denoted by ball and stick. (B) Cot 
distances of the aligned residues between holo- and apo-DmpF. The space gaps represent 
nonaligned residues. Three-dimentional structures of chains H (holo) and F (apo) of 
DmpF were aligned using SSM (http://www.ebi.ac.uk/msd-srv/ssm/cgi-bin/ssmserver). 
Ca distances of the corresponding residues were obtained for drawing the plot. 
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that allow the Rossmann fold of DmpF to bind either cofactor must await determination 
of the crystal structure of a complex with CoASH. 
Conformations of the cofactors in the experimentally observed CoASH 
complexes of succinyl-CoA synthetase (SCS) and formyl-CoA transferase (FCT), and the 
NAD+ complex of DmpF, are remarkably similar. The bound CoASH in succinyl-CoA 
synthetase and formyl-CoA transferase adopts an extended conformation. The distance 
between AC6 and PS1 is 17.3 A in the CoASH of SCS, while it measures 16.5 A in FCT: 
this is comparable with the 16.5 A distance between AC6 and NC4 of NAD+ bound in 
DmpF. The adenine rings of CoASH in both SCS and FCT, as well as the NAD+ in 
DmpF, all are positioned in the anti conformation relative to the ribose group. The ribose 
ring of CoASH in SCS exhibits a l'-exo conformation, not the more common 2'-endo 
conformation observed in CoASH of FCT and NAD+ bound to DmpF, but the difference 
between the two conformations is not believed to be large {103). In the CoASH-SCS and 
NAD+-DmpF complexes, the planes of the adenine ring and the axis connecting 
pyrophosphate are almost perpendicular to each other, whereas the adenine ring of 
CoASH in FCT and the axis are coplanar. These experimentally observed similarities 
support our observations that CoASH and NAD+ share a binding site in DmpF. 
Comparison to Other Proteins with Overlapping Ligand Binding Sites. Our finding 
that the two cofactors of DmpF share a binding site is an enzymatic property not without 
precedent in the literature, although reviews on this topic are scarce. Recently reported 
structures of enzymes with overlapping ligand binding sites include three reductases 
[methylenetetrahydrofolate reductase {105, 106), flavin reductase PheA2 (707, 108), and 
66 
quinone reductase typel (109, J10)], and two other enzymes [chalcone synthase (111) 
and biosynthetic thiolase (112)]. 
These enzymes exhibit a diverse range of folds but share some common features. 
First, the substrates binding to the overlapping site often possess common structural 
elements; local conformational changes may also promote the recognition and binding of 
substrates. Second, these examples have in common ping-pong reaction mechanisms in 
which one of the substrates binds first and then a product is released to vacate the site for 
binding the next substrate. During catalysis, the formation of a covalently bound 
intermediate enzyme complex may be involved, e.g., a polyketide-S-Cys64 intermediate 
in chalcone synthase, acetyl-S-Cys89 intermediates in biosynthetic thiolase, and an 
acetyl-S-Cysl32 intermediate in DmpF (Chapter 3). Third, in the examples cited, van der 
Waals forces dominate the interaction between the enzyme active site and substrates; 
limited numbers of H-bonds and the absence of electrostatic interactions lead to weak 
affinity, which favors the alternate binding and release of substrates and minimizes the 
strong interactions required for distinct recognition of structurally different substrates. 
These features are consistent with the data on DmpF that we report here. 
As is apparently the case with DmpF, overlapping ligand binding sites are also 
associated with the Rossmann fold in a number of other enzymes. Malate dehydrogenase 
(decarboxylating) binds NAD+, a substrate, and ATP, a regulator of catalytic activity, at a 
Rossmann fold with common binding interactions around their ADP moieties (113-115). 
Glyceraldehyde-3-phosphate dehydrogenase, the protein structurally most similar to 
DmpF, binds RNA and DNA competitively with NAD+/NADH at a common site in the 
Rossmann fold (116). Furthermore, other dehydrogenases with Rossmann folds, such as 
67 
alcohol dehydrogenase and lactate dehydrogenase, appear to bind RNA at the pyridine 
nucleotide cofactor binding site {116). The data presented here establish that DmpF is a 
member of a class of proteins that can bind multiple substrates at a single Rossmann fold. 
However, to best of our knowledge this is the only example thus far which binds NAD+ 
and CoASH, two cofactors involved in the catalytic cycle of an enzyme. 
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Chapter 3 Covalent Reactions at the Essential Active Site Cysteine of a CoA-
Dependent Aldehyde Dehydrogenase: Insights into Mechanism and Inhibition 
70 
3.1 Abstract 
DmpFG, a bifunctional aldolase/dehydrogenase from Pseudomonas sp. strain CF600, 
catalyzes the last two reactions of the degradation pathway for phenol and methyl-
substituted phenols. This heterotetrameric enzyme cleaves the substrate, 4-hydroxy-2-
ketovalerate, into pyruvate and acetaldehyde in the active site of the DmpG subunit, 
while at the active site of the DmpF subunit, acetaldehyde is oxidized to acetyl-coenzyme 
A. Here we examine the reactivity of the active-site cysteine of DmpF, Cys-132, in 
catalysis and substrate-induced inactivation. Substitution of Cys-132 by Ser resulted in an 
enzyme that exhibited 5,000-fold lower activity relative to WT. Mass spectrometry was 
used to identify a trapped acetyl-Cysl32 adduct formed during turnover. Preincubation of 
DmpFG with acetaldehyde in the presence of oxygen led to inactivation of the 
dehydrogenase, where Cys-132 was shown using mass spectrometry to be oxidized to 
cysteine sulfinic acid. Unhydrated acetaldehyde appeared to be the preferred substrate for 
the enzyme: during turnover of 4-hydroxy-2-ketovalerate by DmpG it may be transferred 
to DmpF via the hydrophobic tunnel shown to bridge the two active sites [Manjasetty, B. 
A., et al. (2003) Proc. Natl. Acad. Sci. U.S.A, 100, 6992-6997], thus avoiding hydration. 
Structural parameters potentially responsible for activation of Cys-132 were also 
examined and compared with other aldehyde dehydrogenases. 
3.2 Introduction 
Pseudomonas sp. strain CF600 uses the c/mp-operon encoded /weta-cleavage pathway 
to catabolize phenol, cresols and dimethylphenols (1). The last two enzymes in this 
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pathway are the gene products of dmpF (32.7 kDa) and dmpG (37.3 kDa), which copurify 
as a heterotetramer (DmpF2DmpG2) (2). DmpG is a metal-dependent aldolase (E.C. 
1.2.1.10) and DmpF is a CoA-dependent aldehyde dehydrogenase (E.C. 4.1.3.39), which 
together convert 4-hydroxy-2-ketovalerate to pyruvate and acetyl-CoA. The toxic 
intermediate in this reaction, acetaldehyde, is oxidized by DmpF in an NAD+- and CoA-
dependent reaction to acetyl-CoA. Channeling of acetaldehyde from the active site of 
DmpG to that of DmpF via a 29 A long connecting hydrophobic tunnel has been 
postulated on the basis of the crystal structure (4). The tertiary structure of DmpF is most 
similar to the aldehyde dehydrogenase superfamily member, glyceraldehyde-3-phosphate 
dehydrogenase. 
Aldehyde dehydrogenases may be subdivided into two sub-families distinguished 
on the basis of cofactor dependence: NAD(P)+ -dependent aldehyde dehydrogenase, and 
NAD(P)+- and CoA-dependent aldehyde dehydrogenase. The former sub-family can be 
further sub-divided into: 1) phosphorylating NAD(P)+-dependent aldehyde 
dehydrogenases, which reversibly oxidize the aldehyde substrate to phosphoester with the 
involvement of inorganic phosphate; and 2) non-phosphorylating NAD(P)+-dependent 
aldehyde dehydrogenases, which irreversibly catalyze aldehyde oxidation to produce the 
corresponding acid. The CoA-dependent enzymes reversibly oxidize the aldehyde 
substrate using NAD(P)+, and transfer it to coenzyme A to make the acyl-CoA product. 
Although unrelated in primary structure, the aldehyde dehydrogenases resemble each 
other in some aspects of catalysis (36). 
Previously-published work has shown that both CoA-dependent aldehyde 
dehydrogenases and phosphorylating NAD(P)+-dependent enzymes follow ping-pong 
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reaction mechanisms during catalysis (38, 48-50, 52). Aldehyde and nicotinamide 
cofactor bind, and NAD(P)H is released prior to the binding of the third substrate, either 
inorganic phosphate or coenzyme A. By contrast, non-phosphorylating NAD(P)+-
dependent aldehyde dehydrogenases have been shown to follow an ordered sequential 
kinetic mechanism, with NAD(P)H dissociating last (34, 45) 
Relatively little mechanistic work has been done on the NAD(P)+ and CoA-
dependent aldehyde dehydrogenases compared to phosphorylating and non-
phosphorylating NAD(P)+-dependent enzymes. It has been shown that both 
phosphorylating (42, 43) and non-phosphorylating NAD(P)+-dependent aldehyde 
dehydrogenases (45) share a similar two-step reaction that involves the acylation and 
deacylation of a conserved cysteine residue at the active site. In the first step, the 
carbonyl carbon of the substrate aldehyde undergoes nucleophilic attack by the cysteine 
thiolate, to form a thiohemiacetal enzyme complex, followed by hydride transfer to 
NAD(P)+ to generate an acylenzyme intermediate. In the second step, the acyl group 
undergoes nucleophilic attack by phosphate or water to produce a phospho-ester or an 
organic acid, respectively. 
Recently, some of the covalent intermediates involved in these reactions have been 
characterized structurally. The architectures of thiohemiacetal and acylenzyme 
intermediates were determined in two recently-solved crystal structures of aspartate-P-
semialdehyde dehydrogenase, a representative of the phosphorylating NAD(P)+-
dependent aldehyde dehydrogenase sub-family (35, 47). Insights into the catalytic 
intermediates of non-phosphorylating NAD(P)+-dependent aldehyde dehydrogenases 
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were gained by characterization of the thioacylenzyme intermediate of E268A-
glyceraldehyde 3-phosphate dehydrogenase from Streptococcus mutans (36). 
Although the reaction mechanisms of phosphorylating and non-phosphorylating 
NAD(P)+-dependent aldehyde dehydrogenases both involve thiolenzyme intermediates, 
the catalytic details of acylation and deacylation differ. The mechanism of 
phosphorylating NAD(P)+-dependent aldehyde dehydrogenases appears to involve a 
catalytic triad, in which a histidine residue deprotonates and activates the active site 
cysteine for nucleophilic attack on the aldehydic carbon to form a thiohemiacetal 
intermediate (35, 38, 117). For the non-phosphorylating NAD(P)+-dependent aldehyde 
dehydrogenases, the positively-charged nicotinamide ring of the bound NAD(P)+, 
accompanied by conformational rearrangement within the active site concomitant with 
NAD(P) + binding, both play roles in stabilizing the cysteine thiolate (41). Additional 
evidence suggests that backbone amide nitrogens from the cysteine residue itself, and the 
adjacent residue, may also contribute to stabilization of the thiolate (39). By analogy with 
serine proteases (118), for both phosphorylating and non-phosphorylating NAD(P)+-
dependent aldehyde dehydrogenases, oxyanion holes have been proposed to stabilize the 
thiohemiacetal oxyanion, as well as facilitate hydride transfer to NAD(P)+ to generate 
acylenzyme intermediate (33, 47). In the last step of the mechanism for phosphorylating 
aldehyde dehydrogenases, phosphate attacks the carbonyl carbon of the acylenzyme to 
generate a tetrahedral intermediate, followed by the release of phosphoester upon the 
collapse of this intermediate (47). In the case of non-phosphorylating NAD(P)+-
dependent aldehyde dehydrogenases, an invariant Glu participates in the deacylation step 
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by orienting and activating a bound H2O molecule for nucleophilic attack on the 
acylenzyme intermediate (34). 
CoA-dependent aldehyde dehydrogenases have been studied much less 
intensively than the other aldehyde dehydrogenase subfamilies. As these enzymes share 
the ping-pong reaction mechanism of phosphorylating NAD(P)+-dependent aldehyde 
dehydrogenases, possess conserved active site cysteine residues, and often require 
sulfhydryl reagents for enzyme activity or stability, catalysis has been proposed to 
involve covalent acyl-S-enzyme intermediates (3, 4, 48, 49, 52, 54). However, no direct 
evidence for an acylenzyme intermediate has been reported previously for a CoA-
dependent aldehyde dehydrogenase. 
Here we report on the kinetics of DmpF, the identification of an acylenzyme 
intermediate during catalysis, and covalent reactions of the active site thiol with oxygen 
and coenzyme A that lead to inactivation. 
3.3 Materials and Methods 
Materials. For expression of recombinant wild-type (WT) and variant DmpFG proteins, 
E. coli C41 (DE3) cells were used (85). The plasmid for expression of WT DmpFG was 
constructed previously using the pT7.5 vector (119). Mutagenic oligonucleotides were 
synthesized by BioCorp Inc., Montreal, Quebec, Canada. The following oligonucleotides 
were used for mutagenesis: 
5'-GCTGATCATGCGCGCCACCGTGTATGTGC-3'(D209A), 




Silent restriction sites (BsePI for D209A and Aval for C132S) were introduced into the 
primers for subsequent identification of successfully introduced mutations in plasmid 
DNA. The bases highlighted in bold denote the recognition sequence of the restriction 
endonuclease in the primers, while underlined bases are those that have been changed for 
site-directed mutagenesis and/or silent mutation to create restriction sites. E. coli XL2-
Blue cells were used for DNA and plasmid amplification. Plasmids were purified using 
the Wizard miniprep kit (Promega). 
Sequencing Grade Modified Trypsin (porcine) from Promega was used for protein 
digestion. CoA, acetyl-CoA and anhydrous acetaldehyde were purchased from Sigma-
Aldrich; dimethylformamide (DMF) was from Honeywell Burdick & Jackson. NAD+ 
was bought from Roche Diagnostics Corporation. 4-Hydroxy-2-ketovalerate (4H2KV) 
was synthesized from the corresponding lactone, as described in a previous report (120). 
Chromatography resins were purchased from GE Healthcare. 
Site-Directed Mutagenesis. DNA manipulations were according to standard methods 
(121). Site-directed mutagenesis to produce D209A and C132S variants of DmpF was 
carried out using the Quickchange method (Stratagene), essentially as described by the 
manufacturer. The template, pCR®2.1 (dmpFG), was prepared by inserting the EcoRl-
Not\ fragment from the dmpFG coding region of a subclone of pVI150, pVI1316A into 
the same sites of the pCR®2.1 vector (Invitrogen®) (1). Mutagenized plasmid DNA was 
prepared from several individual colonies and screened for the presence of the 
appropriate introduced silent restriction site. A small DNA fragment containing the 
mutation was then excised with appropriate restriction endonucleases (Bpull02I/Bsu361, 
generating a 334 bp fragment for D209A and PmaCI/Bpull021, generating a 350 bp 
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fragment, for C132S) and subsequently inserted into these sites in the WTpT7.5 DmpFG 
protein expression plasmid. Successful incorporation of the mutated fragment was again 
confirmed by the silent restriction site analysis. Expression plasmids for each variant 
were sequenced over the mutagenized insert region to insure that no unexpected 
mutations were introduced into the fragment derived from the Quickchange procedure. 
Each purified WT and variant DmpFG protein was further verified by accurate mass 
measurement of intact protein using an ESI-Q-TOF mass spectrometer. The experimental 
masses were as expected for the introduced substitution. 
Protein Purifications. WT and the variant DmpFG proteins were overexpressed in E. coli 
C41 (DE3) cells as described for WT DmpFG (119). Variant D209A was purified by the 
method previously reported for WT protein (119). Variant C132S did not bind efficiently 
to the NAD+ affinity column, so phenyl-Sepharose chromatography was used for further 
purification after the DEAE chromatography step. The pool of DEAE column fractions, 
which had been pre-adjusted to 10% (NH^SC^ saturation, was loaded onto a phenyl-
Sepharose column (36 cm x 2.6 cm) equilibrated with 50 mM Na+ K+ phosphate buffer 
containing 1 mM DTT ("PD buffer") and 10% saturated (NH4)2S04. The column was 
then washed with this buffer (200 mL), followed by a gradient (200 mL/200 mL) of 10% 
saturated (NH4)2S04 in PD buffer to 50mM PD buffer at a flow rate of 2 mL/min, 
collecting 6 mL fractions. Based on SDS-PAGE analysis (122), the fractions with 
purified DmpFG protein exclusively were combined, subjected to buffer exchange and 
then concentrated and stored, as described previously (119). 
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Protein concentrations were determined by combination of the modified BCA 
(Pierce) method (J23) and 280 nm absorbance detection where one unit of absorption at 
280 nm was estimated to correspond to a 0.62 mg/mL of protein concentration (124). 
Estimation of Steady-State Kinetic Constants. Acetaldehyde dehydrogenase activity of 
DmpFG is defined as the rate of NAD+ reduction (measured at 340 nm) in the presence of 
acetaldehyde and coenzyme A. The kinetic constants were estimated using initial 
velocities at different substrate concentrations, and fitting the data to the Michaelis-
Menten equation using GraFit 5 (125). The assays were initiated by the addition of the 
enzyme (210 ug/mL C132S or 0.75 ug/mL WT and D209A) to 50 mM HEPES buffer 
(pH 8, 25 °C) containing 1 mM DDT, varying concentrations of each of the three 
substrates and fixed concentrations of the other two substrates (568.5 uM NAD , 128.2 
uM CoA and 38.7 mM acetaldehyde). To investigate the aldehyde dehydrogenase kinetic 
mechanism, both initial velocity and product inhibition experiments were performed. In 
the initial velocity experiments each of the three substrates, NAD+, acetaldehyde and 
coenzyme A, was varied while the other two substrates were maintained in the general 
concentration range of their Michaelis constants. In the product inhibition experiments 
initial velocity measurements were conducted where the concentration of substrate, CoA 
or NAD+, was varied at several fixed concentrations of product, either NADH or acetyl-
CoA. Product inhibition patterns were examined using Lineweaver-Burk plots. 
NAD+, CoA and NADH concentrations were determined spectrophotometrically 
using molar extinction coefficients of E260 = 18,000 CUT'M"1, £260 = 16,800 cm'M"1 and 
8340= 6,220 cirf'M"1, respectively (126). Acetaldehyde concentration was estimated with 
alcohol dehydrogenase (127). The concentration of L(S)-4H2KV (1) was taken as 
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identical to that of the NADH generated by coupling DmpG with DmpF under conditions 
where all 4H2KV was depleted. 
Generation of Acylenzyme Intermediate. Acetyl-enzyme intermediate from the back 
reaction was produced by incubating 0.17 nmol of WT DmpFG protein (or 0.19 nmol of 
C132S) with 0.27 nmol of acetyl-CoA for 1 min (10 min for C132S) at 22 °C in 50 mM 
HEPES buffer (pH 8). Then, samples were analyzed by mass spectrometry or 
immediately digested with trypsin (1:12 ratio, w/w with protein) for 2 h at 37 °C. 
Digestion was quenched by adding TFA (final pH~2) followed by storage at -80 °C until 
mass spectrometric analysis. 
Sample preparation from the forward reaction was carried out by incubating 0.17 
nmol of WT DmpFG protein (or 0.19 nmol of C132S) with 20.5 nmol of NAD+ and 4 
umol of acetaldehyde prepared in H2O (or, alternatively, 59.4 nmol of DmpG substrate, 
4-hydroxy-2-ketovalerate) for 30 sec (3 min for C132S) at 22 °C in 20 mM HEPES 
buffer (pH 6.5). Samples were subsequently dried using a SpeedVac at room temperature 
to remove the unreacted acetaldehyde. After being dissolved in 50 mM HEPES buffer 
(pH 8), the dried samples were either subjected to intact protein mass analysis or to 
trypsin digestion as detailed above. 
Acylenzyme Intermediate Identification with Mass Spectrometry. The tryptic peptide 
analyses of DmpFG by either MALDI or ESI-Q-TOF mass spectrometry were performed 
as described previously (119), as was full-length sequencing of targeted peptides using 
HPLC-ESI-Q-TOF. Protein mass measurement was done using a Waters CapLC system 
coupled to an ESI-Q-TOF 2 mass spectrometer. The CapLC system was equilibrated with 
a mixture of 90% solvent A (97% H20: 3% acetonitrile: 0.1% formic acid) and 10% 
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solvent B (97% acetonitrile : 3% H2O : 0.1% formic acid). The samples were loaded and 
desalted in the Symmetry 300 CI8 trap column (0.35 mm x 5mm) with the equilibration 
solvent. Then the proteins were eluted into the mass spectrometer with a gradient of 10% 
to 90% solvent B over 30 min. 
Unhydrated Acetaldehyde as a Substrate for DmpF. Preliminary experiments with the 
organic solvents acetonitrile, acetone, dimethoxyethane, dimethylforamide and 
tetramethylurea showed that no alteration of DmpF activity was observed in the presence 
of 1% dimethylforamide or tetramethylurea (v/v) in the reaction buffer. Thus, 
dimethylforamide (DMF) was used for the preparation of acetaldehyde in non-aqueous 
solvent. 
Two sets of experiments were executed to investigate whether hydrated or 
unhydrated acetaldehyde is a preferred substrate in the DmpF reaction. In the first set of 
experiments, all three assays were performed in 50 raM HEPES buffer (pH 8) at 22 °C 
containing 1 mM DTT, 284.2 uM NAD+, 67 uM CoA, 39 nM DmpF and 5.9 mM total 
acetaldehyde concentration. Acetaldehyde was delivered to the assay in different ways. 
One assay was initiated by addition of acetaldehyde prepared in DMF. A second assay 
was started by addition of DmpFG as the last component to the assay mixture: 
acetaldehyde prepared in DMF had been allowed to pre-equilibrate in the assay buffer for 
5 min. A third assay with anhydrous acetaldehyde in DMF and carbonic anhydrase was 
performed as for the assay initiated with acetaldehyde from DMF, except that carbonic 
anhydrase (0.2 mg/mL) was included in the assay mixture. 
The second set of experiments consisted of two assays, done at pH 7.5 in either 50 
mM Na+ K+ phosphate or 50 mM HEPES buffer at 22 °C, with identical substrate 
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concentrations to the experiments described in the previous paragraph. However, these 
assays were each started by addition of acetaldehyde in DMF to the assay mixture as the 
last component. 
To estimate the half-life of acetaldehyde hydration in 50 mM Na+ K+ phosphate or 50 
mM HEPES buffer (pH 7.5) at 22 °C, 100 uL of 1.2 M acetaldehyde in DMF was mixed 
with 900 u.1 of either buffer, and the absorbance decrease at 280 nm was recorded, 
representing the carbonyl signal disappearance during its hydration {128). The equations 
Abs = 0.909 + 0.6067e-9031tand Abs = 0.882 + 0.6456e"07982t perfectly fit the data with 50 
mM Na+ K+ phosphate and 50mM HEPES buffers, respectively. The half-life values of 
acetaldehyde hydration in both buffers were calculated based on these equations. 
Acetaldehyde-Mediated DmpF Inactivation. Acetaldehyde-mediated DmpF inactivation, 
and the effects of NAD+ and DTT on the inactivation, were carried out in a series of 
related experiments. These assays were performed in 50 mM HEPES buffer (pH 8.0), 
with 492.5 uM NAD+, 130.3 uM CoA, 60 mM acetaldehyde and 10.8 nM WT enzyme. 
The DTT concentration, when present, was 1 mM. The standard assay was started by 
adding the enzyme to the DTT-containing reaction mixture. The acetaldehyde-mediated 
inactivation in the presence of DTT was performed by pre-mixing acetaldehyde with the 
enzyme in the DTT-containing buffer prior to addition of the other reactants. 
Acetaldehyde-mediated inactivation without DTT was carried out similarly except buffer 
without DTT was used instead. To examine NAD+ protection against inactivation, NAD+ 
was incubated with the enzyme in assay buffer lacking DTT followed by addition of 
acetaldehyde, then other assay components. Similar experiments were applied to the 
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variant C132S enzyme using 468.5 nM NAD , 128. uM CoA, 3.84 M acetaldehyde and 3 
uMC132S. 
To study which form of acetaldehyde more efficiently mediates DmpF inactivation, 
two comparison experiments were performed. In one, the aldehyde in DMF was added to 
the DmpFG-containing assay mixture to incur the inactivation, while in the other 
acetaldehyde was hydrated by pre-equilibrating an identical aliquot of acetaldehyde 
prepared in DMF in the assay buffer before mixing with the enzyme to start the 
inactivation. The other reactants were added in the same order for the two experiments. 
Both experiments were performed at 22 °C in 50 mM HEPES buffer (pH 8), containing 
284.2 uM NAD+, 67 uM CoA, 39 nM enzyme and 43.9 mM acetaldehyde. 
Calculation of Solvent Accessible Surfaces. The atomic solvent accessibility of residue 
Cys-132 of DmpF was estimated using CSU software {129) 
(http://bip.weizmann.ac.il/oca-bin/lpccsu). 
3.4 Results 
Site-Directed Mutagenesis of Cys-132 and Asp-209 in DmpF. In common with other 
aldehyde dehydrogenses, a conserved cysteine residue in DmpF has been postulated to be 
essential for catalysis. Chemical modification studies indicated that the dehydrogenase 
activity of DmpFG was inactivated by thiol-directed reagents (3): sequence analysis and 
crystal structure data suggested that Cys-132 is an active site residue (4). Substitution of 
Cys-132 by serine incurred no changes of fluorescent and far-UV CD spectra (data not 
shown), however, decreased kcat approximately 5000-fold (Table 3.1), indicating an 
important role for this residue in catalysis. 
On the basis of the crystal structure, and by comparison with related dehydrogenases, 
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apparent Km (mM) 
NAD+ 
0.156 ±0.011" 




0.043 ± 0.004 
0.0091 ± 0.003 
acetaldehyde 
38.9 ±3.4 




32.2 ± 0.91 
0.0066 ± 0.001 
30.4 ± 1.13 
a
 adapted from reference (119). 
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Asp-209 in DmpF was proposed to function as a general base to activate the thiol group 
of Cys-132 (4). The side chain oxygen of Asp-209 is 5.9A away from the sulfur atom of 
Cys-132, locating it in a position to activate the Cys-132 thiol group via a bound H2O 
molecule. However, for the variant where Asp-209 was replaced by Ala, kinetic 
parameters were very similar to WT DmpF (Table 3.1). This excludes the possibility that 
Asp-209 is required to act as a general base to activate Cys-132. 
Evidence for Acylenzyme Intermediate Formation at Cys-132 of DmpF. In common with 
other NAD(P)+ and CoA-dependent aldehyde dehydrogenases (48, 51, 52, 54), DmpF 
follows a bi uni uni uni ping-pong mechanism (Figure 3.1) on the basis of initial velocity 
and product inhibition studies. In initial velocity experiments where either the NAD+ or 
acetaldehyde concentration was varied, with the other two substrate concentrations at a 
constant ratio, a set of intersecting lines was obtained in Lineweaver-Burk plots (Figure 
3.2A and 3.2B). When CoA concentration was varied, a set of parallel lines was obtained 
instead (Figure 3.2C). In product inhibition experiments both products NADH and acetyl-
CoA exhibited competitive inhibition relative to CoA and NAD+ (Figure 3.3), 
respectively. These data are consistent with the kinetic mechanism shown in Figure 3.1. 
For enzymes catalyzing ping-pong reactions, a covalent intermediate is often, but 
not always, observed. A covalent acylenzyme intermediate, symbolized F in the kinetic 
mechanism shown in Figure 3.1, would be formed during either the forward or backward 
reaction. Thus, it may be possible to capture acylenzyme forms of DmpF either by: 
incubating with the substrates NAD+ and acetaldehyde; incubating with the substrates 
NAD+ and 4-hydroxy-2-ketovalerate, which is cleaved to acetaldehyde and pyruvate by 
the associated DmpG; or by reaction with the product, acetyl-CoA. 
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Figure 3.1 Bi uni uni uni ping-pong reaction mechanism scheme for DmF. 














|acetaldehyde]=9.6 mM, |CoAJ=34.1 nM 
[acetaldehyde]=4.8 mM, [CoAJ=17.1 ^M 
|acetaldehyde]=2.4 mM, |CoA]=8.5 \M ^ ^ 
• ^ ^ ^ 
m^^W ^^^^"^ 
. ^ - — L ^_____—-— 
i i i i i 
^— • 
i i 
0.000 0.005 0.010 0.015 0.020 0.025 
1/[NAD+] (nM)"1 
0.030 0.035 










• |acetaldehydej=60 raM, |NAD+]=0.48 mM 
A
 [acetaldehydej=30 mM, [NAD+]]=0.24 mM 
• [acetaldehydel=15 mM, [NAD+J=0.12 mM 
0.0 0.1 0.2 0.3 
l/[CoA] (pM)"1 
Figure 3.2 DmpF initial velocity patterns with varying concentrations of each of the three 
substrates and the other two substrates in constant ratio as indicated in the insets. 
(A) With NAD+ as the varied substrate and the concentrations of acetaldehyde and CoA 
in constant ratio. 
(B) With acetaldehyde as the varied substrate and the concentrations of NAD+ and CoA 
in constant ratio. 
(C) With CoA as the varied substrate and the concentrations of NAD+ and acetaldehyde 
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Figure 3.3 Product inhibition of DmpF by NADH or acetyl-CoA. 
(A) Inhibition by NADH relative to CoA. The concentrations of NAD+ and acetaldehyde 
were held at 492 uM and 65 mM, respectively. The NADH concentrations are indicated 
in the inset. (B) Inhibition by acetyl-CoA relative to NAD+. The concentrations of 
acetaldehyde and CoA were held at 10.6 mM and 45.1 uM, respectively. The acetyl-CoA 
concentrations are indicated in the inset. 
ESI-Q-TOF spectra showed that a 42 Da adduct of intact DmpF was obtained under 
all three conditions, (Figure 3.4A and data not shown), consistent with the formation of a 
covalent acetyl-DmpF complex. MALDI-TOF spectra of tryptic digests of modified 
enzyme generated by either forward or backward reactions demonstrated an extra peptide 
of 2274.17 Da ([M+H]+), which represents modification of the 2232.17 Da peptide 
([M+H]+) by 42 Da, corresponding to an acetyl group (compare Figure 3.5A with 3.5B, 
and data not shown). This modified peptide, not present in control experiments lacking 
substrates or product (Figure 3.5A), was tentatively assigned as the fragment comprising 
residues 125-146 of DmpF, based on its predicted molecular mass of 2232.13 Da 
([M+H]+). 
In the ESI-Q-TOF spectra of peptides from tryptic digests of the intermediate 
enzyme complex, a doubly-charged species at m/z 1137.56 Th corresponds to a 2274.12 
Da peptide, while a doubly-charged ion at m/z 1116.56 Th corresponds to the unmodified 
peptide, with a mass 42 Da lower (Figure 3.6A, 3.6B and data not shown). HPLC-ESI-
MS/MS was performed to sequence the doubly-charged peptides with m/z 1116.56 Th 
and 1137.56 Th. The results show that the species with m/z 1116.56 Th represents the 
doubly charged peptide corresponding to residues 125-146 of DmpF (Figure 3.7, Table 
3.2), while the peptide with m/z 1137.56 Th corresponds to the modification of peptide 
125-146 of DmpF with an acetyl group (42 Da) addition on Cys-132 of the sequence 
(Figure 3.8, Table 3.2). Thus, the acetyl-S-Cysl32 DmpF intermediate can be generated 
from both catalytic directions, and is stable enough under the experimental conditions 
used to be identified by sequencing the modified peptide and comparing those results to 
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Figure 3.4 DmpF intact protein masses determined by ESI-Q-TOF: 
(A) WT DmpFG incubated with acetyl-CoA; similar results were obtained by incubating 
WT DmpFG with NAD+ and acetaldehyde or with NAD+ and 4-hydroxy-2-ketovalerate 
(data not shown). (B) WT DmpFG incubated with acetaldehyde and (C) the C132S 
variant incubated with acetyl-CoA; similar results were obtained by incubating the 
C132S variant with NAD+ and acetaldehyde or with NAD+ and 4-hydroxy-2-ketovalerate 























2220 2240 2260 m / z 
Figure 3.5 Partial range of isotopic envelopes of MALDI-TOF spectra of tryptic digests 
of (A) WT DmpFG or (B) WT DmpFG incubated with acetyl-CoA. Similar spectra were 
observed for the tryptic digests of samples obtained by incubating WT DmpFG with 
NAD and acetaldehyde or with NAD+ and 4-hydroxy-2-ketovalerate (data not shown). 
Partial range of isotopic envelopes of MALDI-TOF spectra of tryptic digests of the (C) 
C132S variant or (D) C132S variant incubated with acetyl-CoA. Similar spectra were 
observed for the tryptic digests of samples obtained by incubating C132S with NAD+ and 
acetaldehyde or with NAD+ and 4-hydroxy-2-ketovalerate (data not shown). 
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1110 1120 1130 
Figure 3.6 Partial range of isotopic envelopes of ESI-Q-TOF spectra of tryptic digests 
of (A) WT DmpFG and (B) tryptic digest of WT DmpFG incubated with acetyl-CoA. 
Similar spectra were obtained for tryptic digests of samples prepared by incubating WT 
DmpFG with NAD+ and acetaldehyde or with NAD+ and 4-hydroxy-2-ketovalerate (data 
not shown). Partial range of isotopic envelopes of ESI-Q-TOF spectra for (C) tryptic 
digest of WT DmpFG incubated with acetaldehyde, (D) tryptic digest of C132S variant 
and (E) tryptic digest of C132S variant incubated with acetyl-CoA. Similar spectra were 
obtained for the tryptic digests of samples obtained by incubating the C132S variant with 
















































































































































U i | 







































































- - 4 
94 
Table 3.2 Deconvoluted Fragment Ions from MS/MS Analysis of the 1116.56 Th and 
1137.56 Th ([M+2H]2+) Peptides of WT DmpFG 

































































































































































Active Site Reactivity of the Cysl32Ser Variant of DmpF. The data shown in Table 3.1 
indicate that the C132S variant of DmpF is still active, albeit with a greatly depressed &cat. 
To investigate whether a covalent adduct was formed by this variant, mass spectrometry 
experiments were applied to it in parallel with the WT. In analogy with those 
experiments, described above, interpretation of these data are consistent with the 
presence of an acetyl-0-Serl32 DmpF intermediate (Figure 3.4C, 3.5C, 3.5D, 3.6D, 
3.6E, 3.9, 3.10 and Table 3.3). 
Optimization of Conditions for Observation of Acylenzyme Intermediates. Conditions 
required to observe acylenzyme intermediates had to be determined empirically. The rate 
of formation of acetyl-DmpF appeared to depend on pH, in the range of pH 6 to 9: the 
higher the pH, the faster the formation of acetyl-DmpF as judged by mass spectrometry 
(data not shown). At pH 8, under the conditions indicated in Material and Methods, 
almost all WT DmpF reacted to form acetyl-S-DmpF within one min at room 
temperature, as judged by the relative intensities of peaks of modified and unmodified 
intact protein in ESI mass spectra (for example the data shown in Figure 3.4 A were 
obtained after one min incubation). The C132S variant took a much longer time to be 
converted into acetyl-O-DmpF (data not shown). However, the acetyl-S-DmpF 
intermediate was not stable past one min at pH 8 as indicated by the observation that the 
relative intensity of modified DmpF decreased, and that of unmodified DmpF grew 
stronger, with increased incubation times (data not shown). The acetyl-O-DmpF 
intermediate was more stable than its acetyl-S-DmpF counterpart, which is similar to the 
case of p-ketoacyl thiolase from Zoogloea ramigera {130). However, when DmpF 
acylation reactions were quenched by denaturing the protein or decreasing to low pH 
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after a short reaction time, the relative intensities of modified and unmodified proteins 
did not change over time, suggesting that the acetyl-DmpF complex was stable when 
unfolded or under acidic conditions. 
Conditions for the preparation of trypsinized samples also had to be optimized for 
observation of the acylenzyme intermediates. To trap the acetyl-DmpF intermediate from 
the backward reaction, acetyl-CoA was incubated with DmpFG for one min at pH 8 and 
room temperature, and then a high concentration of trypsin was added to digest the 
acetyl-DmpF as soon as possible before more acetyl-DmpF could hydrolyze to free 
DmpF. In the forward reactions, DmpFG was incubated with either NAD and 
acetaldehyde or with NAD+ and 4-hydroxy-2-ketovalerate, and the unreacted 
acetaldehyde was removed prior to trypsin digest, otherwise the unreacted acetaldehyde 
modified the free amino group at the N-terminal of the digest peptides and some exposed 
amino groups after protein denaturation (data not shown). Low pH buffer (6-6.5) was 
used for the forward reaction to keep the formed acetyl-DmpF more stable during 
removal of the unreacted acetaldehyde with the Speedvac. The dried sample was then 
dissolved and adjusted to pH ~ 8 for optimal digestion by trypsin. 
Unhydrated Acetaldehyde as a Substrate for DmpF. The results in the previous section 
showed that Cys-132 at the active site of DmpF is capable of forming an acetyl-enzyme 
intermediate consistent with the kinetic mechanism shown in Figure 3.1. Attack of the 
active site thiol on the aldehyde of the substrate would be facilitated if the functional 
group were not hydrated. In fact, the very high Km (38.9 mM, Table 3.1) for acetaldehyde 
suggests that exogenous acetaldehyde equilibrated in water may be a very poor 



































































































































































































































































Table 3.3 Deconvoluted Fragment Ions from MS/MS Analysis of the 1108.57 Th and 
1129.58 Th ([M+2H]2+) Peptides of the C132S Variant 


































































































































































substrate was examined by initiating the reaction with acetaldehyde from organic solvent, 
as has been done previously with other dehydrogenases (131-133). 
When the DmpF activity assay was initiated by addition of acetaldehyde in 
dimethylforamide (DMF) to 50 mM HEPES buffer (pH 8) containing 284 uM NAD+ and 
67 uM CoA, as well as DmpFG and 1 mM DTT, the initial rate was clearly faster than in 
the reaction where acetaldehyde in DMF was allowed to equilibrate in the assay buffer 
for five min and DmpFG was added last (Figure 3.11A). An identical result was obtained 
when acetaldehyde prepared in HEPES buffer was added as the last component (data not 
shown), showing that the initial rate increase could not be explained by preincubation of 
DmpFG with NAD+, CoA and DTT. Furthermore, when carbonic anhydrase, which 
promotes the hydration of acetaldehyde (134), was included in assays initiated by 
addition of acetaldehyde from DMF, the initial rapid reaction period was drastically 
shortened (Figure 3.11 A). The activity burst became shorter with higher concentrations 
of carbonic anhydrase (data not shown). Finally, the initial rate of DmpF activity when 
acetaldehyde in DMF was added last varied, depending on whether the assay was done in 
HEPES or phosphate buffers (Figure 3.1 IB), This correlates with the hydration half-life 
of acetaldehyde, which was observed to be 0.87 min in 50 mM HEPES buffer (pH 7.5) 
and only 0.077 min in 50 mM phosphate buffer (pH 7.5) at 22 °C. Together, these results 
indicate that higher DmpF activity is associated with a higher effective concentration of 
unhydrated acetaldehyde. 
Acetaldehyde-Mediated DmpF Inactivation. Preincubation of enzyme with CoA or 
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Figure 3.11 The effect of acetaldehyde hydration on the initial rate of DmpF. 
The reaction buffers contained 1 mM DTT, 284 uM NAD , 67 jxM CoA, 39 nM enzyme 
and 5.9 mM acetaldehyde prepared in DMF. Note that traces are offset for clarity. 
(A) Assays were performed in 50 mM HEPES buffer (pH 8) at room temperature 
(ca. 22 °C). The assay with anhydrous acetaldehyde was initiated by the addition of 
acetaldehyde in DMF. The assay with equilibrated acetaldehyde was started by the 
addition of DmpFG enzyme, so that acetaldehyde delivered from DMF was 
preequilibrated in the assay buffer. The assay with anhydrous acetaldehyde and carbonic 
anhydrase was performed as the assay with anhydrous acetaldehyde in DMF except that 
0.2 mg/mL of carbonic anhydrase was included in the reaction buffer. 
(B) Assays were carried out in 50 mM Na+ K+ phosphate or HEPES buffer (pH 7.5) at 
room temperature. The reactions were started by addition of acetaldehyde in DMF to the 
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Figure 3.12 Acetaldehyde-mediated inactivation of DmpF, and protection by NAD+. 
The assays were performed in 50 mM HEPES buffer (pH 8) with 493 uM NAD+, 130 
uM CoA, 60 mM acetaldehyde and 10.8 nM enzyme: when present, the DTT 
concentration was ImM. Enzyme was added as the last component to the standard assay 
mixture containing DTT (1). Acetaldehyde-mediated inactivation was performed by 
mixing acetaldehyde with the enzyme in the DTT-containing buffer before addition of 
other reactants, and the reaction was started by adding CoA last (2); this experiment was 
repeated using buffer without DTT (3). NAD+ protection against acetaldehyde-mediated 
inactivation was carried out by mixing NAD+ with the enzyme in the absence of DTT and 
the reaction was initiated by addition of CoA last (4). 
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inhibition by 1 mM DTT (119) (Figure 3.12) suggests that inhibition by these substrates 
resulted from the oxidation of a thiol group on the enzyme. Essentially no inhibition by 
pre-incubation with CoA or acetaldehyde was observed in the C132S variant of DmpF 
indicating that the active site thiol of DmpF is the residue susceptible to oxidation (Figure 
3.13). As previously reported, 1 mM DTT rescued CoA-mediated inactivation, consistent 
with disulfide formation between the thiol groups of CoA and Cys-132 (119). However, 
although the presence of DTT protected against inactivation by acetaldehyde (Figure 
3.12), it could not recover acetaldehyde-inactivated DmpF after it had been generated 
(data not shown). These results suggest that more than one oxidized form of Cys-132 
may be formed by incubating acetaldehyde with the enzyme. 
Mass spectrometry was employed to further examine the nature of acetaldehyde-
mediated DmpF inactivation and the oxidation state of Cys-132. Upon incubation with 
acetaldehyde alone, DmpF underwent a 32 Da modification (Figure 3.4 B). Formation of 
acetaldehyde adducts with a-amino groups (30), e-amino groups (31), or thiol groups (32) 
of proteins has been reported previously. These acetaldehyde-protein adducts were 
identified to be imidazolidinone or thiazolidine derivatives, which give mass increments 
of 26 Da (755, 136). Although 26 Da adducts were observed when DmpF was digested 
with trypsin in the presence of excess acetaldehyde (data not shown), removal of 
acetaldehyde using the Speedvac prior to digestion resulted in only the 32 Da adduct 
being observed. 
Information about the position of modification was obtained by tryptic digestion and 
sequencing of the modified peptides. ESI-MS analysis of tryptic digests revealed an 
additional doubly-charged peptide of m/z 1132.58 Th present in tryptic digests of 
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DmpFG incubated with acetaldehyde, compared to enzyme that had never been incubated 
with acetaldehyde (compare Figure 3.6A with 3.6C). The doubly-charged ion with m/z 
1132.58 Th was sequenced using MS/MS and found to correspond to residues 125-146 
of DmpF, with a 32 Da modification on Cys-132 (Figure 3.14, Table 3.4). The [M+H]2+ 
ion at m/z 1132.58 Th was not observed when DmpFG was incubated with acetaldehyde 
in an oxygen-free glove box (data not shown). Together, these data are consistent with 
the addition of two oxygen atoms to Cys-132 to form cysteine sulfinic acid (-SO2H), 
resulting in inactivation of DmpF activity. 
In order to establish whether acetaldehyde and oxygen-mediated DmpF inactivation 
was catalyzed by metal ions, acetaldehyde was mixed with DmpFG prior to addition of 
the other reactants as in Figure 3.12, but in the presence of 0.2 mM 
diethylenetriaminepentaacetic acid (DTPA) or 5 mM ethylenedinitrilotetraacetic acid 
(EDTA), respectively. No effect was incurred by DTPA or EDTA on the inactivation of 
DmpF (data not shown), suggesting that metal ions are not required for acetaldehyde-
mediated inactivation of DmpF. 
Since the anhydrous form of acetaldehyde was observed to support faster initial rates 
of DmpF turnover (Figure 3.11), acetaldehyde-mediated inactivation of DmpF was also 
investigated by inactivating DmpF with acetaldehyde prepared in DMF vs. acetaldehyde 
equilibrated in water. Acetaldehyde delivered from DMF incurred more extensive 
inactivation of DmpF than acetaldehyde in DMF equilibrated in buffer first (Figure 3.15). 
Furthermore, inactivation in the former case appeared to produce more Cys-132 sulfinic 
acid than in the latter case, as judged by relative peak heights of modified and unmodified 
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Figure 3.13 Effects of preincubation with acetaldehyde or CoA on activity of C132S 
DmpF. 
Assays were performed in 50 mM HEPES buffer (pH 8) with 469 uM NAD+, 128 uM 
CoA, 3.84 M acetaldehyde and 3 \iM enzyme: when present, the DTT concentration was 
1 mM. CoA-mediated inacativation without DTT was carried out by pre-mixing CoA 
with the enzyme in the buffer in the absence of DTT prior to addition of the other 
reactants, and the reaction was started by adding acetaldehyde last. The other assays were 
done as described for the corresponding ones for WT in Figure 3.12 except that no NAD+ 






















































































































































Table 3.4 Deconvoluted Fragment Ions from MS/MS Analysis of the 1132.58 Th Peptide 
n2+-([M+2HH of WT DmpFG upon incubation with acetaldehyde 
y ion adduct b ion adduct y ion adduct b ion adduct 
Leu1 2 5 
A s n 
V a l 
A s n 
M e t 
V a l 
Thr 
Cys 
G l y 
G l y 
Gln1 3 5 





1 6 9 2 . 8 6 
1 5 9 3 . 7 9 
1492 .74 
1 3 5 7 . 7 3 
1 3 0 0 . 7 1 
1 2 4 3 . 6 8 
-
228 .14 
3 2 7 . 2 1 
4 4 1 . 2 5 
5 7 2 . 3 0 
671 .36 





Ala 1 3 6 
Thr 
Leu 
P r o 
Met 
V a l 
A l a 
A l a 
V a l 





8 3 0 . 4 6 
7 3 3 . 4 1 
602 .36 
5 0 3 . 3 0 
4 3 2 . 2 6 
3 6 1 . 2 3 




1 4 3 4 . 6 6 
-
-
1 7 6 1 . 8 6 
1832 .80 
1 9 0 4 . 0 1 
2003 .08 
-
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Figure 3.15 The effect of acetaldehyde hydration on acetaldehyde-mediated inactivation 
of DmpF. 
The reaction buffer (pH 8) contained 284 uM NAD+, 67 uM CoA, 39 nM enzyme, 1 mM 
DTT and 44 mM acetaldehyde. DmpF reaction in the presence of anhydrous 
acetaldehyde ( ) was carried out by adding acetaldehyde in DMF to the enzyme-
containing buffer, followed by inclusion of DTT, acetaldehyde in H20, CoA and NAD+ 
(added last). DmpF inactivation in the presence of equilibrated acetaldehyde ( ) was 
performed by preincubating acetaldehyde in DMF with buffer for 5 min, followed by 
addition of DmpFG enzyme, DTT, acetaldehyde in H20, CoA and NAD+ added last. 
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3.5 Discussion 
The reactivity of the active site cysteine residue of DmpF, a CoA and NAD+ 
dependent dehydrogenase, has been probed under a variety of conditions that shed light 
on its involvement in catalysis and inhibition. Site-directed mutagenesis established that 
replacement of Cys-132 by serine resulted in a 5,000-fold decrease in apparent &cat. 
Structural features that would favour deprotonation of the thiol group of Cys-132 would 
make it a more effective nucleophile for attack on the carbonyl carbon of the substrate, 
acetaldehyde. However, unlike the structurally similar phosphorylating glyceraldehyde-
3-phosphate dehydrogenase (777) no residues, such as histidine, which could act as a 
catalytic general base are evident within a 5 A radius of the sulfur atom of Cys-132 (4). 
We have previously speculated that Asp-209 might activate a water molecule for 
deprotonation of the Cys-132 thiol (4), but site-directed mutagenesis results reported here 
showed that this residue is not essential. 
It is therefore evident that thiol group activation would have to be induced by other 
elements of the microenvironment around the Cys-132 side chain. By inspection, in the 
X-ray structure of the DmpFG-NAD+ complex (PDB entry: 1NVM), the nicotinamide 
ring is approximately 4 A away from the sulfur atom of Cys-132: its positive charge 
would favor the formation of the thiolate. Furthermore, Cys-132 is located at the N-
terminal of helix H7 (residues 132-154), and the Cys-132 thiol group is near the N-
terminal of helix HI 2 (residues 289-310), where N-terminal helix dipoles would assist in 
stabilizing the thiolate anion of the side chain [as has been postulated for other proteins, 
e.g. (757)]. It should also be noted that the amide NHs of both Cys-132 and Gly-133 are 
close enough to potentially hydrogen bond to the thiol group of Cys-132, which would 
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also favor the formation of thiolate. All of these structural features that could help 
stabilize the thiolate form of the Cys-132 side chain may also facilitate deprotonation of 
the thiol group of coenzyme A in the active site to attack the acyl-DmpF intermediate and 
generate the product, acetyl-CoA. 
Instability of the acetyl-DmpF intermediate in the folded protein and under 
alkaline conditions was an obstacle that had to be overcome for characterization of this 
complex. Several different methods were tried in order to capture the acetyl-DmpF from 
the backward reaction, where the enzyme was incubated with the product, acetyl-CoA. 
Acetone with HC1 (0.5% w/v) or TCA (10% w/v) were used to denature and precipitate 
any protein-bound intermediates as described in a procedure for P-ketoacyl thiolase 
(J30); however, the precipitated protein failed to dissolve properly in buffer suitable for 
the subsequent trypsin digest. Immobilized pepsin worked well for acetyl-DmpF 
digestion at pH 2.5 and 4 °C, conditions under which the acetyl-enzyme complex was 
stable. However, overlapping digestion by pepsin led to generation of more peptides than 
trypsin digestion, and none of the peptides containing the modified Cys-132 residue was 
observed in MALDI spectra, although the peptide of residues 130-142, including Cys-
132, was well-identified as a doubly-charged ion (m/z 624.29Da) in ESI-Q-TOF spectra 
(data not shown). The unpredictability of cutting sites during pepsin digest also added 
more complications to full-length peptide sequencing. In the simple and successful 
method of sample preparation that is described in Materials and Methods, porcine trypsin 
was selected to digest the intermediate complex since bovine trypsin can autolyze a 
2273.16Da peptide ([M+H]+) which would overlap with the acetyl adduct of peptide 
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125-146 of DmpF (2274.13Da in [M+H]+) in both MALDI and ESI spectra, causing 
identification difficulties. 
Mass spectrometry showed that formation of acyl enzyme at Cys-132 occurs from 
either direction (Figure 3.1), as would be expected if it is involved in catalysis. Covalent 
acyl-enzyme intermediates have been detected previously in both phosphorylating and 
non-phosphorylating NAD(P)+-dependent aldehyde dehydrogenases (35, 36, 47). This is 
the first time that an acyl-enzyme intermediate has been experimentally shown to be 
formed in a CoA-dependent aldehyde dehydrogenase. Attack of the cysteine thiolate on 
the carbonyl group of acetaldehyde should involve the non-hydrated form of the 
substrate, which hydrates in pure water at 25 °C to form a 1.06 : 1 mixture of hydrated 
and non-hydrated forms (138). Therefore it was of interest to assay DmpF activity using 
hydrated and non-hydrated forms of acetaldehyde. 
All of the evidence collected was consistent with non-hydrated acetaldehyde being a 
better substrate for DmpF than the hydrated form. It has been previously shown that the 
anhydrous form of aldehyde is a more effective substrate for such enzymes as yeast 
aldehyde dehydrogenase (132), and yeast and human liver alcohol dehydrogenases (132, 
133, 139). DmpF exhibited a high Km value for substrate aldehyde prepared in H20, a 
feature common to many other NAD(P)+ -and CoA- dependent aldehyde dehydrogenases. 
Thus, Km values for the aldehyde substrate ranged from 2.2 to 10 mM for the following 
enzymes: CoA-linked aldehyde dehydrogenase from Escherichia coli (49); CoA-
dependent succinate-semialdehyde dehydrogenase from Clostridium kluyveri (51); CoA-
acylating aldehyde dehydrogenase from Clostridium beijerinckii NRRL B592 (50); CoA-
linked acetaldehyde dehydrogenase from Clostridium acetobutylicum (53); CoA-linked 
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acetaldehyde dehydrogenase from Leuconostoc mesenteroides (140); and CoA-linked 
acetaldehyde dehydrogenase from Acetobacterium woodii (54). Some others exhibited 
lower Km values, in the range 0.15 mM to 0.45 mM, including CoA-linked acetaldehyde 
dehydrogenases from Clostridium kluyveri (52, 141), aldehyde dehydrogenase (CoA-
acetylating) from Giardia lamblia (76) and the NAD+- and CoA dependent 
acetaldehyde/alcohol dehydrogenase from Entamoeba histolytica (142). The high Km 
value measurements for aldehyde substrate suggest that, for the NAD(P)+ and CoA-
dependent aldehyde dehydrogenases, the aldehyde substrate may equilibrate with the 
hydrated form, which is not an effective substrate. 
The observation that DmpF appears to be more active with the non-hydrated form of 
acetaldehyde may be significant in the context of the bifunctional nature of the enzyme. 
The X-ray structure of the tightly-associated DmpFG heterotetramer revealed that a 
hydrophobic tunnel connects the active site of DmpF with DmpG, which is where 
acetaldehyde is generated from 4-hydroxy-2-ketovalerate (4). If acetaldehyde travels 
through this tunnel to the active site of DmpF, it may remain unhydrated until it is 
attacked by the thiolate of Cys-132. The tunnel in this case may help to improve the 
efficiency of the enzyme by maintaining the substrate in a more reactive form by keeping 
it sequestered from the bulk solvent. 
Interestingly, many CoA-dependent aldehyde dehydrogenases that are involved in 
alcohol fermentation have aldehyde/alcohol bifunctionality (48, 76, 140, 142-144). Thus, 
both acetaldehyde dehydrogenase and alcohol dehydrogenase activities are incorporated 
in a single protein molecule which reversibly catalyzes the reduction of acetyl-CoA to 
alcohol via acetaldehyde as an intermediate. It would be interesting to know if there are 
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special architectural features in these bifunctional aldehyde dehydrogenases, such as the 
hydrophobic tunnel in DmpFG, which would allow anhydrous transport of acetaldehyde 
to the alcohol dehydrogenase catalytic site. 
Oxygen sensitivity has previously been investigated in some CoA-dependent 
aldehyde dehydrogenases. CoA-dependent aldehyde dehydrogenase from Clostridium 
beijerinckii NRRL B592 was found to be significantly sensitive to O2, and DTT was 
required to protect against inactivation during protein purification and activity assay (50). 
Incubation of 02-inactivated enzyme with CoA or CoA plus DTT was found to restore 
activity. Coenzyme A-linked acetaldehyde dehydrogenase from Acetobacterium woodii 
(54) and the coenzyme A-dependent succinate-semialdehyde dehydrogenase from 
Clostridium kluyveri (57) were also reported to be susceptible to 02-inactivation. The 
observation that sulfhydryl reagents such as DTT could protect against inactivation in 
these enzymes suggested involvement of one or more essential cysteine residues. 
However, the nature of the oxidation reactions was not determined. 
The results reported here indicate that in the presence of acetaldehyde, particularly 
the non-hydrated form, Cys-132 of DmpF becomes particularly susceptible to oxidation. 
Mass spectrometry showed that Cys-132, in the proposed active site of DmpF, was the 
target for oxidation, undergoing conversion to a form whose mass spectrum is consistent 
with the sulfinic acid. Although DmpF was not very sensitive to oxidation in the absence 
of acetaldehyde, it was still slowly inactivated during long-term storage, with the 
production of detectable amounts of Cys-132 sulfinic acid even when kept at -80 °C. 
Interestingly, in the structure of phosphorylating glyceraldehyde-3-phosphate 
dehydrogenase from Bacillus stearothermophilus, only the reactive glyceraldehyde 3-
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phosphate (non-hydrated form) was found to be bound within the active site of the 
protein despite the favored existence of the hydrated form in equilibrated solutions (64). 
It thus appears that the binding of non-hydrated acetaldehyde to the active site of DmpF 
promotes the sensitivity of Cys-132 to oxidation. 
Protection against inactivation by the continuous presence of DTT, which was 
ineffective after inactivation had occurred, is consistent with previous observations that 
initial thiol oxidation products such as disulfides are reduced by DTT, whereas sulfinic 
acids are not (145). Phosphorylating glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), the structurally most similar aldehyde dehydrogenase to DmpF, has also been 
identified as an oxidant-sensitive enzyme. Loss of enzyme activity was correlated with 
oxidation of the essential cysteine thiol into distinct products depending on the oxidant 
applied. An intramolecular disulfide was generated by iodosobenzoate oxidation (146), 
cysteine sulfonic acid was produced in the presence of H2O2 (147) and a mixture of 
cysteine sulfinic and sulfonic acids, as well as disulfide, was produced by peroxynitrite 
oxidation (145). Furthermore, oxidation of cysteine to sulfinic acid by oxidants such as 
hydrogen peroxide and hypochlorous acid (HOC1) has been reported to occur in many 
other proteins containing an essential cysteine residue (148-151) 
The facile oxidation of active site cysteines in proteins such as GAPDH and 
peroxiredoxins, which are thiol-dependent peroxidases responsible for detoxification of 
reactive oxygen species (152-155), has been proposed to be due to low pKa values for 
their active site cysteine thiol groups (pKa = 5.5 and 4.6 for GAPDH and peroxiredoxin, 
respectively) (156, 157). These low pKa values appear to be a result of stabilization of the 
thiolate by surrounding positive charges. The anion form of a cysteine thiol group is more 
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susceptible to oxidation by peroxides than its protonated form (158). Increased sensitivity 
of Cys-132 to O2 could be explained if acetaldehyde binding to DmpF lowered the thiol 
group pKa of Cys-132, making it more susceptible to oxidation. 
Assay data also showed that pre-binding of the NAD+ cofactor could protect against 
the acetaldehyde-mediated inactivation of DmpF (Figure 3.12). In the case of GAPDH, 
NAD+ binding promoted the reactivity of the essential thiol group with peroxides (147) 
by supplying additional positive charge (156, 159) or altering the local conformation 
within the active site (41) that depressed the pKa of the active site cysteine thiol. 
Accordingly, it is possible that the pKa would decrease as a result of NAD+ binding to 
DmpF, but another possibility is that NAD+ binding would also physically block solvent 
accessibility to Cys-132. Comparison of the solvent accessibility between apo DmpF and 
NAD+-bound DmpF shows that the solvent accessible surfaces for the sulfur atom of 
Cys-132 are 9.2 A2 and 1.6 A2, respectively. The significantly different solvent 
accessibilities would mean that O2 dissolved in buffer becomes much less accessible to 
the thiolate group of Cys-132 upon NAD+ binding to DmpF, leading to the observed 
NAD+ protection against the acetaldehyde-mediated inactivation. Similarly, for GAPDH 
in the presence of substrate, glyceraldehyde-3-phosphate, inactivation by H202 was 
greatly decreased compared to uncomplexed enzyme. This may be due to the formation 
of hemithiolacetyl ester between the substrate and the essential cysteine thiol group, 
which resulted in the protection of the thiol group (147). However, in the case of DmpF, 
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Chapter 4 Active Site Studies and Metal Ion Requirements of DmpG, an Aldolase 
Involved in Bacterial Degradation of Aromatic Compounds 
4.1 Abstract 
DmpFG, a bifunctional aldolase/dehydrogenase, catalyzes cleavage of 4-hydroxy-2-
ketovalerate, a catabolic intermediate in phenol degradation, into pyruvate and acetyl-
CoA via acetaldehyde. DmpG is a divalent cation-dependent class II aldolase belonging 
to the HMGL-like family. In this study, purified DmpFG was shown by ICP-MS to 
contain a total of one equivalent of a mixture of Fe, Mn, Zn and Cu, with Fe and Mn 
predominating. Site-directed mutagenesis combined with ICP-MS and kinetics studies 
were used to probe the roles of amino acid residues observed in the crystal structure to 
coordinate the metal ion at the active site of DmpG. Substitution of any of the three 
metal-binding ligands, D18, H200 or H202, resulted in almost complete loss of Fe and 
*J-i- 0-1- O-J- 0 I 
Mn, and of activity. Addition of Mn , Co , Ni or Cd to the assay increased aldolase 
activity of WT up to approximately 26-fold, and stimulated the activity of the metal 
ligand variants to different degrees. In the presence of Mn2+ or Co2+, H202A aldolase 
activity was restored to activity levels similar to WT, H200A activity was partially 
restored, and D18N activity remained at trace levels. The H200A variant exhibited a 
perturbed fluorescence emission spectrum, suggesting a structural change resulting 
specifically from that substitution. Urea-induced unfolding experiments and analytical 
ultracentifugation experiments indicated that H202A had destabilized secondary and 
quaternary structures in the absence of added metal ion. Although a number of divalent 
metal ions were activating, Zn + was not, and it inhibited the activation by Mn +, Co , 
Ni2+ or Cd2+. Taken together, these results indicate that DmpG contains a tightly bound 




Pseudomonas sp. strain CF600 is able to grow efficiently using phenol and methyl-
substituted phenols via the Jmp-operon encoded meta-cleavage pathway which comprises 
nine enzyme activities (160). The end products of this pathway are pyruvate and acetyl-
CoA, which feed into central metabolism. The last two enzymes in this pathway are the 
gene products of dmpF (32.7 kDa) and dmpG (37.3 kDa) (2). DmpG, a divalent cation-
dependent aldolase, converts 4-hydroxy-2-ketovalerate (4H2KV) into pyruvate and 
acetaldehyde while DmpF, an NAD+-, and CoA-dependent acetaldehyde dehydrogenase, 
oxidizes acetaldehyde to acetyl-CoA. These proteins are purified as an active 
heterotetramer (F2G2) complex, and thus constitute a bifunctional enzyme. Interestingly, 
the aldolase (DmpG) of DmpFG could not be successfully expressed in an active form 
separately from the acetaldehyde dehydrogenase (DmpF) (3). 
Aldolase enzymes may be classified according to metal cation requirement (161). 
Class I aldolases are metal-independent and catalysis involves an intermediate Schiff-
base complex between substrate and an active site Lys within an (a/J3)g TIM barrel 
structural framework. Class II aldolases absolutely require divalent metal cations for 
catalysis, and are further sub-classified based on the type of protein fold (26). Both 
classes of aldolase are exemplified by fructose-1,6-bisphosphate aldolases (FBPA), 
which catalyze the reversible cleavage of fructose-1,6-bisphosphate to dihydroxyacetone 
phosphate and glyceraldehyde 3-phosphate (162). Class I FBPAs from eukaryotes (163-
166) have been well characterized, while less is known about class II FBPAs from 
microorganisms (25-27, 29, 167). 
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In Class II FBPA, catalysis occurs in the metal-containing active site of a (a/p)s 
TIM barrel (25, 28, 168), which is also a structural feature of DmpG (4). The reaction 
involves general base and acid catalysis, and formation of a carbanionic intermediate (25, 
169, 170). The catalytic divalent cation coordinates with the side chains of three histidine 
residues as well as, by inference from a structure of a complex with a transition state 
analogue, the hydroxyl and carbonyl oxygens of the substrate, dihydroxyacetone 
phosphate (DHAP) (25, 28). The metal ion is proposed to polarize the carbonyl bond to 
facilitate C-C bond cleavage. Besides the requirement for divalent cation, either firmly 
bound or dissociable, monovalent cations such as K+ or NH4+ must be present for optimal 
class II FBPA activity (24, 162). The monovalent cation binding site was identified in the 
structures of E. coli FBPA (26, 27), where it was supposed to coordinate substrate 
(DHAP) binding and alignment for efficient catalysis (25). 
The HMGL-like family is a recently-recognized group of class II aldolases which 
comprises 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) lyase, a-isopropylmalate 
synthase (a-IPMS), transcarboxylase (TC) 5S subunit and DmpG (5). Structures of the 
four proteins of the family have been solved recently (4, 6-9). Members of this family 
feature a conserved active site located in the (alf>)% TIM barrel catalytic domain, and thus 
are likely to use similar reaction mechanisms to catalyze divalent cation-dependent C-C 
bond cleavage or condensation. Similar to class II FBPA, the mechanism of HMGL-like 
enzymes has been proposed to involve general base and /or acid catalysis and carbanion 
intermediate formation (6). 
HMGL-like family members have been crystallized for structure determination either 
with or without added metal ions. DmpFG was crystallized in the absence of added 
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divalent cation as a tetrameric dimer in which two DmpG subunits associate with one 
another, and DmpF subunits stack at either end of the DmpG dimer (4). The DmpG 
subunit was observed to have bound metal ion coordinated in octahedral geometry with 
the side chains of Asp-18, His-200 and His-202, together with one ordered H2O oxygen 
and two carbonyl oxygens from a unidentified ligand that was proposed to be oxalate 
(PDB entry: 1NVM). Human 3-hydroxy-3-methylglutaryl-CoA lyase was crystallized in 
buffer containing Mg +, which is essential for enzyme activity. In this case, a single 
metal ion was observed in the crystal structure ligated in octahedral geometry to side 
chains of Asp-42 , His-233 and His-235, Asn-275 and two H2O oxygens (PDB entry: 
2CW6) (7). Bacterial 3-hydroxy-3-methylglutaryl-CoA lyases were crystallized from 
94-
solutions with high concentrations of Ca , which has no effect on the enzyme activity 
but likely mimics the catalytic metal ion (PDB entries: 1YDO and 1YDN) (6). The Ca2+ 
9+ 
ion was observed to have similar coordination as Mg in the human homologue. a-
Isopropylmalate synthase from Mycobacterium tuberculosis was crystallized from 
94-
solution containing Zn , which is an inhibitor of the enzyme (PDB entry: 1SR9) (8, 21). 
The metal ion was observed to be bound to Asp-81, His-285, His-287, one H2O oxygen 
and two carbonyl oxygens of the substrate, a-ketoisovalerate. Finally, transcarboxylase 
5S subunit from Propionibacterium shermanii (PDB entries: 1S3H, 1U5J, 1RQB, 1RQE, 
1RR2 and 1RQH) (9), was expressed in medium containing Co + and Zn +, and one Co + 
9+ 
was observed in the active site of the protein. The Co was coordinated by the side 
chains of Asp-23, His-215, His-217, as well as one H2O oxygen and two carboxyl group 
oxygens from bound substrate. 
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Although proteins of the HMGL-like family share only 12% - 23% primary sequence 
identity, they demonstrate significant similarity in the active site stereo arrangement 
based on the three dimensional structural alignments (14, 171). As detailed above, a 
divalent cation is ligated by the side chains of one aspartate and two histidine residues [in 
the conserved motif of HXH (172)], with one additional Asn ligand in HMG-CoA lyase, 
together with one ordered H20 oxygen and at least one oxygen from substrate with 
overall octahedral geometry. Furthermore, inspection of the structures indicates that the 
metal ligand residues in each family member are precisely aligned and stabilized by 
similar hydrogen bond networks. 
Interestingly, in all HMGL-like family members a conserved arginine residue (R17 in 
DmpG) interacts with a conserved glutamate residue near the metal-binding ligands. The 
arginine side chain was proposed to be involved in neutralization of the negative charge 
generated on the enolate catalytic intermediate, according to the structural analysis of 
pyruvate- and oxaloacetate-transcarboxylase 5S complexes (1RQH and 1RQE) (<5). The 
conserved divalent cation was observed to interact with two carbonyl groups of the 
substrate in the substrate-protein complex of either a-isopropylmalate synthase or 
transcarboxylase 5S subunit (1SR9 and 1RQE), supporting the notion that the metal ion 
of HMGL-like proteins participates in catalysis by polarizing the carbonyl bond of the 
substrate. 
The catalytic general acid/base appears to be unique for each HMGL-like family 
member. A conserved cysteine residue of HMG-CoA lyase was assigned to be the 
general base, based on its position in the structure and enzyme kinetic data for a variant 
(6, 15). In a-IPMS, two conserved residues, His-379 and Glu-218, are potential general 
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bases, and an ordered H2O molecule is the candidate for general acid (5). In DmpG, a 
pair of residues, His-21 and Tyr-291, was proposed to deprotonate the substrate, 4H2KV, 
and protonate the pyruvate enolate intermediate, respectively, during catalysis (4). 
The active site residues of DmpG were investigated here, to better define the role of 
the metal ion using a variety of metal ions and metal-binding variants, and to investigate 
the proposed involvement of active site residues in aldolase activity. 
4.3 Materials and Methods 
Materials. In ICP-MS experiments, the single-element standards Fe, Mn, Zn, Ni, Cd and 
multi-element standard containing Al, As, Co, Cr, Cu, K, Na, P and Pb were 
purchased from SPEX CertiPrep®, Inc. 
Construction of plasmid DNA for expression of the DmpG variants H200A, 
H202A and H203A was described previously (173). The following primer pairs 
(Biocorp Inc., Montreal) were used for site-directed mutagenesis to generate the 
DmpG variants R17Q, D18N, H21A, H21Q, Y291A and Y291F: 
5' CGTAACCCTGCAGGACGGCAGCCATGCC 3' and 
5' GGCATGGCTGCCGTCCTGCAGGGTTACG 3' (R17Q) 
5' CGTAACCCTGCGCAACGGCAGCCATGCC 3' and 
5' GGCATGGCTGCCGTTGCGCAGGGTTACG 3' (D18N) 
5' CTGCGTGACGGCAGCGCTGCGATTCGCCACCAGTACAC 3' and 
5' GTGTACTGGTGGCGAATCGCAGCGCTGCCGTCACGAAG 3' (H21A) 
5' CTGCGTGACGGCAGCCAAGCGATTCGCCACCAGTACAC 3' and 
5' GTGTACTGGTGGCGAATCGCTTGGCTGCCGTCACGCAG 3' (H21Q) 
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5' GGATATGCCGGTGTCTTTTCAAGCTTCCTGC 3' and 
5' GCAGGAAGCTTGAAAAGACACCGGCATATCC 3' (Y291F) 
5' CTCGGATATGCCGGTGTCGCTTCAAGCTTCCTGCGTCACGCC 3' and 
5' GGCGTGACGCAGGAAGCTTGAAGCGACACCGGCATATCCGAG 3' (Y291A) 
Silent restriction sites (Pstl for R17Q, Avill for D18N, Tfil for H21A and H21Q, Hindlll 
for Y291A and Y291F) were introduced into the primers for subsequent identification of 
successfully introduced mutations in plasmid DNA. The bases highlighted in bold denote 
the restriction enzyme recognition sites in the primers, while underlined bases are those 
that have been changed for site-directed mutagenesis and/or silent mutation to create 
restriction sites. 
Site-Directed Mutagenesis. pCR®2.1 (dmpFG) (Chapter 3) was used as a template in the 
Quickchange mutagenesis method (Stratagene) for preparation of DmpG site-directed 
variants. Mutagenized plasmids were amplified in E. coli XL2-Blue and subsequently 
purified using the Wizard miniprep kit (Promega). Mutagenized regions of the expression 
plasmid encompassing R17Q, D18N, H21A or H21Q were excised on a 566 bp Bsu36l-
Sphl fragment. For the variants Y291A or Y291F, the mutagenized DNA was excised on 
a 350 bp Sphl-Notl fragment. These fragments were inserted into the corresponding 
restriction sites in the WT pT7.5 based DmpFG expression plasmid (119). Subsequently, 
each plasmid DNA was checked by sequencing over the insert region, to insure that only 
the expected mutation had been introduced. Furthermore, exact mass measurement of 
purified intact proteins (with the exception of D18N) using ESI-Q-Tof 
126 
MS showed that the experimental mass difference between variant and WT proteins was 
consistent with only the introduced substitution (data not shown). Since the D18N protein 
has only a one Da mass difference compared to WT, the intact protein was digested with 
immobilized pepsin, and MS/MS sequencing of peptic peptide 14-31 (J 19) showed that 
Asp-18 of DmpG was replaced by Asn in the variant protein (data not shown). 
Protein Expression and Purification. All the variant DmpFG proteins, R17Q, D18N, 
H21A, H21Q, H200A, H202A, Y291A and Y291F, were expressed and purified as 
previously described for WT {119). However, the D18N, H21A and H21Q proteins were 
eluted from the NAD+ affinity column with 0.5 M NaCl in 50 mM Na+ K+ phosphate 
buffer (pH 7.5) instead of 0.1 M NaCl, which was sufficient to elute WT and the other 
variant DmpFG proteins. 
Kinetics Experiments for DmpFG. Acetaldehyde dehydrogenase activity was estimated 
using the procedure described previously (Chapter 3). Kinetic constants for acetaldehyde 
dehydrogenase activity were estimated using initial velocities of reactions that were 
carried out in 50 mM HEPES buffer (pH 8, 25 °C) at varying concentrations of NAD+ or 
CoA with fixed concentrations of the other two substrates: acetaldehyde (38 mM), NAD+ 
(570 |iM) or CoA (120 uM). Aldolase activity was estimated by monitoring the rate of 
NAD+ reduction through coupling with the acetaldehyde dehydrogenase reaction of 
DmpFG. The assay was initiated by addition of DmpFG to metal-free 50 mM HEPES 
buffer mixture (pH 8) containing the substrate, 4H2KV, and experimentally saturating 
concentrations of NAD+ (554 uM) and CoA (107 uM), in the presence or in the absence 
of added divalent cation. Apparent kinetic parameters for aldolase activity were estimated 
using initial velocities at varying divalent cation or 4H2KV concentrations, respectively, 
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at fixed concentration of substrate, 4H2KV (132.7 uM for the assays of metal ligand 
variants in the presence of Mn2+, and 75.8 uM for all the other assays with WT and metal 
ligand variant enzymes), or divalent cation (10 mM Mn2+, 5mM Co2+, 2.5mM Ni2+ or 125 
uM Cd2+). Specific activities of either WT or variant enzymes were calculated using 
initial rates observed in metal-free 50 mM HEPES buffer (pH 8, 25 °C) containing 554 
uM NAD+, 107 uM CoA, 133 uM 4H2KV and, if present, 10 mM Mn2+ or 5 mM Co2+. 
Preparation of 4H2KV and concentration determination for the substrates, 4H2KV, 
acetaldehyde, NAD+ and CoA, were as described previously (Chapter 3). 
Preparation of samples to measure the effects of Fe + on the aldolase activity of 
DmpFG was carried out under anaerobic conditions. Stock solutions of ferrous ion were 
prepared by dissolving ferrous chloride or ferrous ammonium sulfate in anaerobic Milli-
es H20 in a glove box (M. Braun) where the O2 concentration was under 5 ppm at 22 °C. 
The metal-free 50 mM HEPES assay buffer (pH 8), and substrate-containing solutions 
were all bubbled with N2 and then moved into the glove box. Enzyme samples were 
prepared in the glove box as well. All reaction components except enzyme were 
premixed in a septum-sealed cuvette in the glove box. The enzyme was loaded into an 
airtight syringe in the glove box and then the septum-sealed cuvette and syringe were 
moved out of the glove box. The reaction was initiated by injecting the enzyme through 
the septum into the cuvette, followed by mixing. Progress of the reaction was monitored 
at 340 run. 
Zn2' inhibition of divalent cation-stimulated DmpG activity. Zn2+ inhibition of Mn2+ (or 
Co +) stimulated DmpG activity was investigated by measuring initial velocities of the 
acetaldehyde dehydrogenase through coupling DmpG with DmpF assays: at the 
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concentrations used, Zn showed no effect on the acetaldehyde dehydrogenase activity. 
The assays were performed in 50 mM HEPES buffer (pH 8, 25 °C) containing various 
Mn2+ (or Co2+) concentrations, 554 uM NAD+, 107 uM CoA and 133 uM 4H2KV at 
several fixed Zn2+ concentrations ranging from 0 to 125 uM. The inhibition pattern was 
analyzed using the program of Cleland (174) to fit the assay data points, and the inhibitor 
dissociation constant, K\, was calculated. Assays were also carried out in the presence of 
varying Zn + concentrations and fixed Mn + or Co + concentrations (10 mM or 5 mM, 
respectively), in 50 mM HEPES buffer (pH 8, 25 °C), 554 uM NAD+, 107 uM CoA and 
133 uM 4H2KV. Activity in the absence of Zn was considered to be 100%, and assay 
data were plotted using the IC50 model in GraFit 5 (Erithacus Software) to give an 
estimate of the concentration of Zn which inhibits 50% activity. 
Oxalate inhibition of aldolase activity. Oxalate inhibition of aldolase activity was 
investigated by measuring aldehyde dehydrogenase initial velocities through coupling 
DmpG with DmpF reactions since oxalate showed no effect on the acetaldehyde 
dehydrogenase activity. The assays were carried out in metal-free 50 mM HEPES buffer 
(pH 8, 25 °C) with vaying concentrations of 4H2KV, 554 uM NAD+ and 107 uM 
CoA, at several fixed oxalate concentrations. The oxalate inhibition pattern was analyzed 
using the program of Cleland {174) and the oxalate dissociation constant, K\, was 
calculated. The coupled DmpFG assays were also carried out with a fixed concentration 
of 4H2KV (133 uM) and varying concentrations of oxalate in 50 mM HEPES buffer (pH 
8, 25 °C) with 554 uM NAD+ and 107 uM CoA. Activity in the absence of oxalate was 
considered to be 100%, and assay data were plotted using the IC50 model in GraFit 5 
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(Erithacus Software) to give an estimate of the concentration of oxalate which inhibits 
50% activity. 
Sample Preparation for ICP-MS Experiments. All of the containers, tips and tubes used 
for sample preparation for ICP-MS experiments were polypropylene and soaked in 7% 
HNO3 (w/w, trace metal grade) at least overnight, then rinsed thoroughly with Milli-Q 
H20 (18.2MQ) and dried in a 37 °C incubator prior to use. Metal-free 50 mM HEPES 
buffer (pH 8.0), was prepared by passing the buffer through a column of Chelex®100 
resin (biotechnology grade, 100-200 mesh, sodium form, Bio-Rad Laboratories) which 
was previously washed with 7% HNO3 and Milli-Q H2O. Then the metal-free 50 mM 
HEPES buffer was adjusted to pH 8 with 6N semiconductor grade NaOH solution. 
All protein samples used for metal detection were digested in 10% HNO3 at 50 °C 
overnight, then diluted with Milli-Q H20 prior to analysis. Flowthrough which was 
collected at the end of buffer exchange during protein purification procedures was 
subjected to the same treatment as the sample for use as a control in ICP-MS 
experiments. For samples used to estimate metal ion stoichiometry after incubation with 
excess metal ion, 250 uL of WT DmpFG (in 50 mM HEPES buffer, pH 8) (113 uM) was 
mixed with 2.5 uL of 1 M MnCl2 (10 mM Mn2+ final concentration) or 0.5 M CoCl2 (5 
mM Co + final concentration) and incubated at 22 °C for 10 min. To remove the excess 
metal ion, the mixture was loaded onto a NAP-5 column (GE Healthcare) which was 
previously washed with 200 mM EDTA and equilibrated with metal-free 50 mM HEPES 
buffer (pH 8). Next, 250 uL of 50 mM HEPES buffer (pH 8), was applied to the column 
and the eluate was discarded. Finally the enzyme was eluted with 500 uL of 50 mM 
HEPES buffer (pH 8), followed by collection of an equal volume of flowthrough. 
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Controls were prepared in parallel following the same procedure as above, except that 
250 uL of flowthrough collected at the end of the last step of the protein purification 
procedure was used instead of 250 uL DmpFG. 
ICP-MS Analysis. Metals associated with WT DmpFG and its variants were evaluated 
using an Agilent Technologies 7500ce collision/reaction cell ICP-MS system which 
could be run in three distinct gas modes: hydrogen, helium or no-gas mode. First, semi-
quantitative analysis was conducted to identify the metals present, and their approximate 
amounts. Metal contents were then accurately quantified by using an external calibration 
technique in He mode. To achieve optimal performance, the following ICP-MS 
conditions were used: peristaltic pump speed was 0.1 rps; sampling depth was 8 mm; 
RF power was 1,500 W; and the carrier gas and makeup gas were supplied at flow rates 
of 0.8 and 0.2 L/min, respectively. Helium gas was applied to the reaction cell at 5 
mL/min. 
Circular Dichroism (CD) Spectroscopy. Far-UV CD experiments were conducted at 22 
°C using a JASCO J-815 CD spectrometer. The scans were made between 210-260 nm 
with a step resolution of 0.2 nm, response time of 0.25 s, and bandwidth of 1 nm. Protein 
samples were diluted to 0.5 mg/mL in 50 mM HEPES buffer (pH 8.0) for analysis. 
Fluorescence Spectroscopy. Fluorescence measurements were carried out on an Aminco 
Bowman series 2 Fluorimeter. DmpFG at a concentration of 0.2 mg/mL in 50 mM 
HEPES buffer (pH 8.0) was excited at Xex = 280 nm or 295 nm. The fluorescence 
emission spectra were monitored at 22 °C from 285-400 nm for 280 nm excitation, and 
from 300-400 nm for 295 nm excitation, with a scan rate of 1.0 nm/sec. Samples were 
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contained in a 1.0 cm quartz cuvette. The spectrum of the buffer blank was subtracted 
from all protein spectra. 
Urea-Induced DmpFG Unfolding Experiments. In either the absence or the presence of 
added 1 mM Mn +, DmpFG samples (0.2 mg/mL) were incubated with urea in increasing 
concentration from 0 to 5 M at 22 °C for 16 h. The buffer used was metal-free 50 mM 
HEPES (pH 8.0). Spectra were then acquired between 210 and 260nm at 22 °C: the CD 
signal at 222nm was used to monitor the a-helical content remaining. Before fitting a 
dose-response curve to obtain the [urea] 50% unfolding, which represents the concentration of 
urea that induces 50% unfolding of protein, the CD signal at 222 nm was converted to 
percent intensity with respect to the sample lacking urea. The following equation was 
employed to fit the experimental data using SigmaPlot 9.0: 
max — min 
y = min -\ 
1 + (x / EC50)Hillsl°Pe 
where y is the percent signal intensity, x is the corresponding urea concentration, and 
EC50 represents the urea concentration that incurred 50% protein unfolding. 
Analytical Ultracentrifugation. Sedimentation velocity experiments were performed 
using a Beckman Optima XL-I analytical ultracentrifuge. The sedimentation behaviour 
of DmpFG was examined by centrifuging 400 uL of 0.5 mg/mL samples at 42,000 rpm in 
a 60-Ti rotor at 20 °C. Sedimentation runs were scanned at 280 nm. The sedimentation 
coefficients, S, were obtained by analyzing the data using DCDT+ software (version 
1.14) (775). Reference samples with buffer only were centrifuged side-by-side with the 
protein samples. Sedimentation coefficients were corrected for buffer density and 
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viscosity at different temperatures, which were calculated using the Sednterp 
(Sedimentation Interpretation) program version 1.08 (776). 
4.4 Results 
Aldehyde Dehydrogenase (Acylating) Kinetics of DmpG Variants D18N, H200A and 
H202A. Amino acid substitutions were made for the DmpG metal ligands, D18, H200 or 
H202, generating D18N, H200A and H202A. The effects of each substitution on the 
kinetics of the physically-associated DmpF were examined. The apparent &cat and Km 
values for NAD+ or CoA of H200A and H202A were similar to those of WT (Table 4.1), 
while for D18N the Km was 3-fold lower for NAD+, 3-fold higher for CoA, and kcat was 
2-fold lower compared with WT (Table 4.1). The substitutions at the DmpG active site 
therefore affected the DmpF active site of the bifunctional enzyme minimally. The 
effects of the substitutions on DmpG activity were examined next. 
Metal and Aldolase Activity Measurements of DmpG WT, D18N, H200A and H202A. 
Prior to this work the identity and function of metal ion associated with DmpFG had not 
been rigorously established. ICP-MS showed that WT DmpFG contained Fe, Mn, Zn 
and Cu metals in order of decreasing abundance, with a stoichiometry of one mol DmpG 
subunit to one mol of total metals, with Fe and Mn predominant (Table 4.2). Mutagenesis 
of the metal ligands identified by x-ray crystallography (Asp-18, His-200 or His-202) 
resulted in almost complete loss of Fe and Mn, but elevated Cu contents: total metal 
content was about half of that of WT (Table 4.2). Aldolase activity of these variants was 
decreased to 0.12-2.2% relative to that of WT enzyme, indicating that tightly bound 
metals were associated with the aldolase activity of WT DmpFG in the absence of added 
metal ions. 
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'adapted from reference {119). 
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 adapted from Chapter 3 
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Table 4.2 Metal content and activity of WT and the metal ligand variants of DmpFG 
DmpFG 
metal contenta (mol./mol. DmpG subunit) spec. act.b % of 
Fe Mn Zn Cu Ni Co Cd total («™l./min.mg) spec. act. 
W T 0.58 0.21 0.13 0.06 nd nd nd 0.98 765.0 4.99 
Dim 0.07 - 0.19 0.32 0.04 nd nd 0.62 2.54 0.02 
H200A 0.03 - 0.09 0.30 0.02 nd nd 0.44 0.9 0.01 
H202A 0.02 - 0.01 0.33 0.01 nd nd 0.37 17.08 0.11 
WT + Mn2+ 0.57 0.75 0.18 0.09 0.02 0.01 nd 1.62 15,340 100 
W T + CO" 0.41 0.15 0.12 0.03 nd 1.20 nd 1.91 13,580 88.5 
" - " denotes less than O.Olmol. metal /mol. DmpG subunit; "nd" indicates non-detectable. 
a
 The metal contents were estimated using three different preparations of WT and two 
preparations for each of the metal ligant variants, and each determination was done in 
triplicate. Averages are given in the Table with errors of less than or equal to ± 15 %. 
b
 Specific activities were measured in the absence of added metal ions, except WT + 
Mn2+ and WT + Co2+ assays which were carried out in the presence ofMn 2 + (10mM) or 
Co2+ (5 mM), respectively. The 50 mM HEPES assay buffer (pH 8, 25 °C) included 554 
uM NAD+, 106 uM CoA and 133 uM 4H2KV. 
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Metal and Aldolase Activity Measurements of Other DmpG Active Site Variants. Three 
active site residues potentially involved in catalysis were targeted for substitution: R17, 
H21 and Y291, as well as H203 which is adjacent to the metal ligand, H202. None of 
these residues was observed as a ligand to the metal ion in the crystal structure: however, 
with the exception of H203 they have been postulated previously to be otherwise 
involved in catalysis (4). The H21A, H21Q and H203A variants contained similar 
amounts of total metal and bound Fe as WT, but significantly less Mn, especially the 
H21Q variant (Table 4.3). Residues R17 and Y291 were previously observed in the 
crystal structure to interact with what appeared to be a substrate or product analogue at 
the active site (4). R17Q, Y291A and Y291F had Fe contents that were decreased 
somewhat relative to WT, and Mn levels that were either the same as WT (Y291 
variants), or similar to the H21 and H203 variants (Table 4.3). The substitutions at R17 
and H21 abolished residual aldolase activity, whereas the specific activities of H203 and 
Y291 were either similar to or half, respectively, that of WT (Table 4.3). 
Effect of Metal Chelators on Aldolase Activity. DmpFG was incubated with either 
ethylenediaminetetraacetic acid (EDTA), o-phenanthroline or 8-hydroxyquinoline-5-
sulfonate (5 mM) at room temperature (22 °C). At intervals over a 24 h period aliquots 
were removed for aldolase activity assay and examination of metal content after desalting 
on a NAP-5 column. A parallel control experiment without any added chelator was 
carried out simultaneously. Incubation of DmpFG with these chelators did not 
significantly alter the metal contents or the aldolase activity in the absence of added metal 
ions compared to the control experiment (data not shown). Therefore, the metal ions 
detected by ICP-MS are tightly bound to the enzyme. 
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Table 4.3 Metal content and activity of WT and variants DmpG without added Me' 
metal contenta (mol./mol. DmpG subunit) „ b 















































































" - " denotes less than O.Olmol. metal /mol. DmpG subunit, "nd" indicates non-detectable 
a
 The metal contents were measured for two different preparations of each of the DmpG 
variants, and each determination was done in triplicate. Averages are given in the Table 
with errors of less than or equal to ± 16 %. 
b
 Specific activity of each variant was measured in 50 mM HEPES buffer (pH 8, 25 °C) 
containing 554 uM NAD+ , 107 uM CoA and 133 uM 4H2KV in the absence of added 
metal ions. 
137 
Stimulation of Aldolase Activity by Divalent Cations. As shown in Table 4.4, Mn or 
9+ 
Co in the assay buffer activated WT aldolase activity 26- and 20-fold over the activity 
9+ 
without added Me , respectively, with corresponding Km values of 1.3 and 0.35 mM. 
Ni2+ enhanced WT DmpG activity 3-fold while Cd2+ only slightly increased the aldolase 
activity. The apparent Km for substrate, 4H2KV, varied up to 5-fold with the various 
metal ions, but was very similar for the two most active cations, Co2+ and Mn2+. 
Surprisingly, Fe + did not enhance aldolase activity when added to the assay even though 
Fe was the most abundant metal detected in WT (data not shown). Together, these data 
suggest the possibility that a more weakly bound divalent metal ion, distinct from the 
metal ion bound by D18, H200 and H202 at the DmpG active site, significantly 
stimulates aldolase activity. Furthermore, it appears that tightly and weakly bound metal 
ions may be the same or different types of ions. 
Effect of Metal Ions on Metal Ligand Variant Activities. As noted above, the metal 
ligand variants of DmpG were all essentially depleted of Mn and Fe (Table 4.2). 
Interestingly, the aldolase activity of H202A could be completely restored by addition of 
Mn + to the assay, and even gained higher activity upon incubation with Co2+ compared 
to the WT enzyme (Table 4.5). In contrast, activity could not be restored to the D18N 
variant with Mn , and only minimal activity was observed with Co . H200A was 
activated with Co , but to a level well below WT: with Mn , activity was low, and the 
Km for metal ion apparently very high compared to WT (Table 4.5). The apparent Km 
values of the substrate, 4H2KV, were similar for WT and the three variants D18A, 
H200A and H202A in the presence of Co2+, but in the presence of Mn2+, considerably 
higher for the H200A and H202A variants compared to WT. As with WT, for all three 
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0.93 ± 0.03 





0.02 ± 0.0002 
— 
apparent Km, 4H2KV 
(uM) 
26.4 ±4.66 
15.8 ± 1.53 
8.2 ±1.33 
5.4 ±0.54 
6.2 ± 0.63 
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&cat K m > M n K m 4 H 2 K V &cat K m > Co Km>4H2KV 
(s"1) (mM) (uM) (s"1) (mM) (uM) 
WT 24.7± 1.75 1.28 ±0.14 26.4±4.66 18.7 =b 1.75 0.35±0.05 26.4±4.66 
D18N - - 0.5 ±0.1 0.18 ±0.05 42.5 ±14.4 
H200A 1.4 ±0.4 66.4 ±31.8 416.3 ±132.1 7.1 ±0.3 1.6±0.1 18.3 ±3.4 
H202A 21.8± 1.9 0.40 ±0.1 112.1 ±15.8 36.2±1.6 0.086 ± 0.02 27.0±2.7 
' -" denotes activity too low to estimate kinetic parameters accurately. 
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variants the apparent Km values for Co were lower than those for Mn : for H200A the 
Km values of the metal ions were considerably higher than those for WT, whereas for 
H202A they were significantly lower. The fact that there may be high and low affinity 
metal binding sites complicates the interpretation of the results as Km values of the three 
DmpG variants may reflect complex affinity of the two types of metal ions. 
Binding of Additional Metal Ion to WT DmpFG. The observation that approximately one 
mol of divalent metal ion is associated with purified DmpFG but that additional metal ion 
is required in the assay for optimal activity suggests that a second metal binding site may 
be involved in catalysis. Additional metal binding was examined by incubating the 
enzyme with Mn2+ or Co2+, followed by removal of the excess on a desalting column and 
quantitation of protein-associated metal ions by ICP-MS. In the control experiments 
without enzyme, elution of the NAP-5 column with 500 \iL of 50 mM metal-free HEPES 
94- 94-
buffer (pH 8) resulted in no Mn or Co being detected above that in control samples 
prepared without incubation with metal ion. However, when the NAP-5 column was 
eluted with 500 uL buffer applied to the protein samples in the column, 1.6 and 1.9 mol 
94- 9+ 
of total metal content to one mol of DmpG subunit were obtained for Mn and Co 
incubation, respectively, representing significant increases over the one mol of metal 
present originally (Table 4.2). Since there is only one metal ion accommodated by the 
HMGL-familty associated Asp-His-His metal binding motif observed by x-ray 
crystallography, this result may reflect the existence of a second divalent cation binding 
site. 
Secondary, Tertiary and Quaternary Structure Probes of Metal Ligand Variants. Far-UV 
CD showed that all three metal ligand variant proteins, D18N, H200A, and H202A, 
141 
shared similar secondary structure contents with WT DmpFG, since the spectra were 
almost identical in the range of 210-260 nm (Figure 4.1). 
The tertiary structures of the variants were probed using fluorescence spectroscopy. 
The emission spectra of WT, and the variants D18N and H202A, when excited at 280 nm 
or 295nm, showed similar peak shapes and emission A,max of 310 nm and 333 nm, 
respectively, although there were minor differences in intensities (Figure 4.2). The 
variant H200A had a similar fluorescence emission spectrum to WT and the other 
variants when excited at 295 nm (Figure 4.2B), but upon excitation at 280 nm the 
emission Xmax of H200A was red-shifted by 10 nm to 320 nm, and the peak was 
broadened considerably (Figure 4.2A). The inability to fully activate this variant with 
metal ion (Table 4.5) may be associated with the perturbed structure reflected by the 
changed fluorescence properties. 
Analytical ultracentrifugation (AUC) experiments were carried out to probe whether 
metal ligand substitution affected the quaternary structure of DmpFG. The three variant 
proteins all showed similar peaks at 6S, similar to WT, which corresponds to the 140K 
Da of biological tetramer of DmpFG (Figure 4.3 A). 
Structural Stability of Metal Ligand Variants. To further investigate the effects of metal 
ligand replacement on structural stability, DmpFG WT and variant proteins were 
subjected to thermal and chemical denaturation experiments. Preliminary results showed 
that either thermal or guanidine-HCl-mediated denaturation caused insoluble precipitates 
of WT to form {173). Thus, urea was used as the denaturant, and unfolding/denaturation 
was monitored using far-UV CD and AUC. WT and variants D18N, H200A or H202A, 
were equilibrated with 0-5 M urea, then the a-helical content of the samples was 
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examined at 222 nm using far-UV CD. The a-helical fractional content decreased as a 
function of urea concentration with [urea]5o% unfolding of 3 M, 2.3 M, 2.1 M and 0.7 M for 
WT, D18N, H200A and H202A, respectively (Figure 4.4). Therefore, WT DmpFG was 
more resistant to urea-induced unfolding than the variant proteins indicating that DmpFG 
was destabilized upon mutagenesis of the metal ligands. 
Next, the effects of added Mn2+ on unfolding by urea were examined. Similar 
denaturation profiles were observed for WT, and variants D18N and H200A in the 
presence or absence of 1 mM Mn + (Figure 4.4). However, the H202A variant was 
markedly stabilized to urea-induced unfolding in the presence of added Mn , with a shift 
of [urea]50% unfolding from 0.7 M in the absence of Mn2+ to 2.8 M in its presence, bringing 
the stability very close to that of WT in the absence of added divalent metal ion (Figure 
4.4). 
The effects of urea on WT and the H202A variant were also examined by AUC. Only 
a single protein species sedimenting at 6S was observed for WT in the presence or 
absence of 0.5 M urea, as expected for the 140 KDa DmpFG tetramer (Figure 4.3). For 
the H202A variant, the tetramer was observed in the absence of urea (Figure 4.3 A); in the 
presence of 0.5 M urea, besides the 6S peak, a species with sedimentation coefficient of 
1.8S appeared, consistent with the dissociation of DmpFG to 30K-40K Da monomers 
(Figure 4.3B). 
Effect of Monovalent Cations on DmpG Activity. The effect of monovalent cations on 
DmpG activity in the absence of and in the presence of divalent cations was investigated. 
In the presence of 50 or 100 mM Li+, Na+, K+, Rb+ or NFL}+ in the assays, no significant 
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Figure 4.1 Far-UV CD spectra of DmpFG WT and the three metal ligand variant 
proteins. 
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Figure 4.2 Fluorescence spectra of DmpFG WT and the three metal ligand variant proteins. 
(A) Spectra obtained by excitation at 280 nm; (B) spectra obtained by excitation at 295 nm. 
The samples were prepared in 50 mM HEPES buffer (pH 8) with final concentration of 
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Figure 4.3 Analytical ultracentrifugation of DmpFG protein. 
(A) Sedimentation velocity for WT and the three metal ligand variant proteins; (B) 
sedimentation velocity for WT and variant H202A proteins in the presence of 0.5 M urea. 
The buffer used was 50 mM metal-free HEPES, pH 8, with 0.5 M urea and samples 
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Figure 4.4 Urea-induced unfolding of DmpFG WT and the three metal ligand variant 
proteins monitored by far-UV CD. 
(A) In the absence of added Mn2+ and (B) in the presence of added Mn2+. The 
experiments were carried out in 50 mM metal-free HEPES buffer, pH 8, without added 
Mn2+ or with added 1 mM Mn2+, and containing 0.2 mg/mL of protein. 
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regardless of whether the assays were carried out in HEPES or Tris-HCl buffers (data not 
shown). 
Zn + Inhibition of Divalent Cation-Stimulated DmpG Activity. At a low Zn2+ 
concentration (0-125 uM), no effect on adolase activity was observed in the absence of 
added divalent cation in assays: higher concentrations of Zn2+ caused turbidity in the 
assay buffer and precluded enzyme activity detection. However, low concentrations of 
Zn strongly inhibited Mn - or Co -stimulated DmpG activity: the higher the Mn or 
Co + concentration, the stronger the Zn + ion inhibition. As well, Zn + decreased both the 
Vmax and Km values for the stimulating cation, which is characteristic of uncompetitive 
inhibition (data not shown). Inhibition by Zn was quantitated by calculating K, and IC50 
values in the presence of added MnZT or Coz (Table 4.6). 
Oxalate Inhibition of Aldolase Activity. Oxalate, an analogue of pyruvate which is a 
product of the DmpG reaction, was found to competitively inhibit aldolase activity of 
DmpFG with respect to the substrate, 4H2KV (data not shown). Oxalate inhibits DmpG 
activity with an IC50 of 6.1 uM and #=0 .49 uM (Table 4.6). 
Mutagenesis of Potential Catalytic Residues at the Active Site oj DmpG. Arg-17 is 
conserved in the HMGL-like family members, while His-21 and Tyr-291 are unique for 
DmpG; however they are all located at positions where they may be involved in DmpG 
catalysis, according to the crystal structure (4). Site-directed mutagenesis was performed 
to investigate these residues' potential involvement in aldolase activity. Activity was not 
detectable in variants R17Q or H21A/H21Q without added divalent cation, while 
Y291A/Y291F activity was similar to WT (Table 4.2 and 4.3). In the presence of added 
Mn + or Co +, variants R17Q, H21A and H21Q showed significant, but low, aldolase 
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activity relative to WT (Table 4.7 and 4.2). Variant Y291A and Y291F activities 
increased slightly in the presence of added Mn2+ or Co2+, but were still only 9 and 16%, 
respectively, compared with WT (Tables 4.2 and 4.7). 
Detection of Intermediate Carbanion in Aldolase Catalytic Reaction. Tetranitromethane 
(TNM) has been successfully used to trap the carbanionic enzyme-substrate intermediates 
of fructose 1,6-bisphosphate aldolases from either rabbit muscle {170) or yeast (169). 
TNM was reduced to nitroformate, which strongly absorbs at 350 nm, by the carbanionic 
intermediates generated during the reaction. In Co2+-containing buffer, incubation of WT 
DmpFG with substrate, 4-hydroxy-2-ketovalerate, or the product, pyruvate, either of 
which might be expected to produce enolate carbanions, failed to show any evidence of 
nitroformate formation (data not shown). 
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Table 4.6 Effects of inhibitors Zn and oxalate on DmpG activity 




8.8 ± 0.7 (Mn2+) 11.2 ± 2.1 (Mn2+) 
9.0 ± 0.9 (Co2+) 16.3 ±1.8 (Co2+) 
0.49 ±0.08 6.1 ±0.9 
Table 4.7 Specific activity of DmpG WT and variants with added Me' 
specific activity a (nmol./min.mg) 
variant 
with added Mn2+ with added Co2+ 
WT 15,340 13,580 
R17Q 2.2 2.7 
H21A 11.4 20.1 
H21Q 8.0 17.5 
Y291A 1,340 2,020 
Y291F 1,370 2,512 
a
 The specific activities were estimated in 50 mM HEPES assay buffer (pH 8, 25 °C) 
containing 554 uM NAD+, 107 uM CoA and 133 uM 4H2KV with addition of 10 mM 
Mn + or 5 mM Co +. The values shown are the average of three determinations, with 
errors of less than or equal to ± 13 %. 
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4.5 Discussion 
The active site of DmpG was investigated using site-directed mutagenesis. One 
group of targeted residues comprised the three metal ligands observed in the crystal 
structure (4), D18, H200 and H202, which are all strictly conserved in the HMGL-like 
family (<5). Another group of residues identified as potentially important for catalytic 
mechanism, R17 (<5), H21 and Y291 (4), were also targets for mutagenesis. 
The metal ligand variants, D18N, H200A or H202A, all showed dehydrogenase 
activity and substrate binding affinities similar to WT, as might be expected since they 
are remote from the DmpF active site (Table 4.1). The small differences that were 
observed may reflect structural coupling between the DmpF and DmpG subunits that was 
evident in the crystal structure (4). The similarity in dehydrogenase activities allowed a 
coupled activity assay to be used to investigate and compare aldolase kinetics in the 
variants. 
Determination of the DmpFG structure showed that the DmpG active site included a 
metal ion, even though the enzyme was crystallized in the absence of any added metal 
salts (4). The ICP-MS studies reported here showed that one DmpFG dimer contained 
one equivalent of a mixture of Fe, Mn, Zn and Cu, of which Fe and Mn were 
predominant (Table 4.2). These tightly-bound metals, which could not be removed by 
various chelators, only supported residual aldolase activity (~5% of optimal, Table 4.2). 
Site-directed mutagenesis of the active site metal ligands, Asp-18, His-200 and His-202, 
led to almost complete loss of Fe and Mn (Table 4.2): the increased Cu content of some 
of the variants suggests that Cu may also bind at the same site, but the lower specific 
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activity suggests decreased functionality of Cu . The broad selectivity suggests a flexible 
metal binding site within the DmpG active site. 
The effects of replacing each of the metal ligands varied. The most pronounced 
effect on activity was observed in the D18A variant. Tightly bound Fe and Mn were 
almost completely lost (Table 4.2): activity in the absence of added metal ions was also 
lost and could not be stimulated by Mn2+, and only to a small extent by Co2+ (-3% of 
WT) (Table 4.4 and 4.5). Although biophysical probes of secondary, tertiary and 
quaternary structure showed that this variant was very similar to WT (Figures 4.1, 4.2 
and 4.3A), the fact that binding to the NAD+ affinity column became tighter suggested a 
conformational change in this variant, at least in the DmpF subunit. The stability to 
denaturation by urea was lower than WT, and was not affected by the addition of Mn + 
(Figure 4.4). Taken together, these results suggest that removal of D18 results in an 
enzyme that is unable to bind active site metal to regain activity. Removal of the 
aspartate ligand may have a larger effect than removal of either of the histidine ligands, 
as the carboxyl sidechain has higher affinity for Co + or Mn + than does the imidazole 
sidechain. 
Substitution of His-200 with Ala produced a variant with a significantly different 
fluorescence emission spectrum compared to WT, when excited at 280 nm (Figure 4.2A). 
This result is consistent with a significantly perturbed structure for H200A indicating that 
loss of aldolase activity of this variant cannot be exclusively attributed to removal of 
tightly-bound metal ion. Indeed, addition of metal ion only partially restored the aldolase 
activity (Tables 4.4 and 4.5) and the Km for metal ion was far higher than that of WT, 
indicating that the ability of this variant to bind metal was impaired. 
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Replacement of His-202 with alanine also resulted in complete loss of bound Fe and 
Mn, accompanied by almost total loss of aldolase activity (0.11% compared to WT) 
(Table 4.2). However, unlike H200A, the activity of H202A could be restored to levels 
94- 9+ 
similar to or higher than WT aldolase activity by the addition of Mn or Co (Tables 4.4 
and 4.5). In addition, the Km values for the metal ions appeared to be lower than WT, 
which may reflect the combination of affinity for both metal binding sites since most of 
the "tightly-bound" sites of variant H202A were initially unoccupied. This variant 
showed biophysical behavior similar to that of WT in fluorescence, far-UV CD and AUC 
experiments (Figures 4.1, 4.2 and 4.3A). However, it was extremely destabilized to 
94-
denaturation by urea, which was reversed in the presence of Mn (Figure 4.4). AUC 
experiments showed that, unlike WT, this variant dissociated in the presence of a low 
concentration of urea (Figure 4.3B), suggesting that in the absence of metal ion, the 
interaction between subunits in H202A was affected. In the presence of additional metal 
ion, this variant behaved most like WT. Taken together, the results are consistent with the 
notion that the tightly-bound divalent cation is essential for the residual aldolase activity 
of WT DmpFG, and also plays a structural role. 
It has long been established that divalent metal ion is an integral part of the class II 
FBPA active site, and that a monovalent cation also participates in catalysis. In some 
cases, such as FBPA from E. coli, two divalent cation binding sites have been identified 
94-
(25, 168). The "catalytic" Zn site located at the active site in the C-terminal end of an 
(a/p)8 barrel is coordinated by three histidines, HI 10, H226 and H264: the proposed 
function of the catalytic Zn + is to precisely align the substrate in the active site as well as 
serve as a Lewis acid to polarize the carbonyl bond of the substrate for efficient catalysis 
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(25, 177). A second Zn was proposed to organize and stabilize the catalytic site (25, 
168), but as the secondary binding sites were observed upon soaking crystals with 
solutions containing excess divalent metal ion it is not clear whether these sites represent 
specific or non-specific binding. This uncertainty was further enhanced by the 
observation that only one Zn atom was detected in the purified holo-protein (24, 178). 
Interestingly, the Zn atom only supported residual activity of the enzyme (14% of the full 
activity) whereas full activity depended on the presence of K+ in the assay (24). 
Similar observations have been made regarding metal ion participation in the other 
three HMGL-Iike family members, HMG-CoA lyase, a-isopropylmalate synthase, and 
transcarboxylase. As with DmpG, all of these enzymes have been observed by x-ray 
crystallography to contain a metal ion coordinated to two His and one Asp residues (6-9). 
Unlike yeast (24, 178) or E. coli (25) FBPA, and a-isopropylmalate synthases (IPMS) 
from Mycobacterium tuberculosis (21), yeast (179) and Neurospora I. (180), where full 
activity depends on the presence of K+, DmpG activity was not stimulated by monovalent 
cations. Similarly, the activities of the other two HMGL-like family members, HMG-
CoA lyase and TC 5S unit, have not been reported to depend on the presence of 
monovalent cations. 
The identity and stoichiometry of divalent metal ion binding varies between HMGL-
family members. Metal analysis of yeast a-isopropylmalate synthases (IPMS) showed 
that one subunit of enzyme contained two Zn atoms (757): one tightly bound, which was 
essential for enzyme activity, and one less tightly bound which was catalytically inactive. 
In contrast, although Mycobacterium tuberculosis IPMS was crystallized with Zn2+ 
9+ 9+ 
bound at the active site, Zn is actually a competitive inhibitor of catalytic Mg (21). 
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Nevertheless, on the basis of the crystal structure, the divalent metal ion was proposed to 
correctly align the substrate and polarize the C-C bond of the substrate for its efficient 
cleavage (8). Various studies of the 5S subunit of transcarboxylase (TC) from 
Propionibacterium shermanti indicated involvement of Co2+, Zn2+ or Cu + ions with a 
stoichiometry of one 5S monomer to two metal ions, and while enzyme with Co2+ or 
Zn + was active, that with Cu2+ had low or no activity (23, 59, 60). The preparation used 
for crystal structure determination was purified from bacteria growing in Co2+- and Zn2+-
containing medium: Co was the metal ion identified by ICP-MS, and a single binding 
site was observed (25). The Co2+ in 5S unit of transcarboxylase was proposed to polarize 
the carboxyl bond of oxaloacetate and promote C-C bond cleavage. 
Amongst the HMGL-family proteins, the best published evidence for a second 
divalent cation binding site is associated with HMG-CoA lyases. Tightly-bound metal ion 
associated with the HXH motif was identified by site-directed mutagenesis studies (17, 
19) and crystallographic evidence (6, 7). For instance, purified HMG-CoA lyase from 
Pseudomonas mevalonii predominantly contained tightly bound Cu + which was 
proposed to be involved in a structural, not a stimulatory, role (20, 182). It is reasonable 
to suppose that the metal ion participates in catalysis by polarizing the carbonyl group of 
substrate, leading to efficient C-C bond cleavage. Despite the presence of tightly-bound 
metal, such as Cu2+, activation by the addition of Mg2+ or Mn2+ to the enzyme assay was 
still observed, suggesting a requirement for a more loosely-associated divalent metal ion. 
The observation that optimal DmpG aldolase activity required the presence of 
divalent metal ion in the assay indicates that the tightly-bound metal ion detected by ICP-
MS in the purified protein is not sufficient. It was possible to augment the metal content 
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of the enzyme by 0.6 and 0.9 equivalent upon incubation with excess Mn2+ or Co2+, 
respectively, followed by gel filtration (Table 4.2). The lower amount of Mn2+ detected 
is consistent with the 3-fold higher Km for this metal ion. These represent lower limits 
for additional metal ion binding to the enzyme and suggest the presence of a second 
metal ion binding site. 
Additional support for a second divalent metal ion binding site was provided by the 
results of experiments on the effects of Zn2+ on aldolase activity. While the activity of 
the enzyme in the absence of additional divalent metal ion in the assay was unaffected by 
Zn2+, Zn2+ acted as an uncompetitive inhibitor of activity in the presence of Mn2+ or 
Co . This result indicates that Zn binds to a site distinct from Mn or Co , and the 
site is only available after Mn2+ (or Co2+) binding, which may trigger protein 
conformational change to make a Zn2+ binding site functional. Conformational change 
incurred by the weakly-bound metal ion may stimulate aldolase activity by inducing 
optimal conformation of the active site and proper substrate orientation. Zn inhibition 
was also observed in a-isopropylmalate synthase from Mycobacterium tuberculosis, but 
was competitive which might result from Zn + substitution for Mg + at the active site and 
from the distinct coordination geometry (21). 
In summary, the class II aldolases discussed above commonly include a metal ion 
binding site at the active centers which involves binding to a divalent cation for catalysis. 
The binding of this metal ion may only support residual activity of the enzymes. The full 
aldolase activities require a second ion to bind, either monovalent cation or divalent 
cation: apparently, the class II FBPAs and a-IPMS need a monovalent cation (e.g. K+) for 
stimulation, while a divalent cation (Mn2+ or Co2+) has to be present for full aldolase 
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activity of DmpFG. While multiple ion involvement in HMG-CoA lyase or TC 5S 
subunit reactions has not been fully delineated, like DmpG there is evidence in the 
reported experimental data that both contain tight- and weak-binding sites for metal ions. 
Oxalate strongly inhibited DmpG activity with a competitive pattern. Estimations of 
IC50 and K\ values were done without added cations in the assay, since oxalate is a well-
known chelator for many divalent cations. The high affinity of oxalate (IC50 = 6.1 uM, K\ 
= 0.49 uM) is consistent with the observation of a ligand in the DmpFG crystal structure. 
In human HMG-CoA lyase, removal of the histidine or aspartate metal ligands 
resulted in enzymes with lower activities, in the order WT>H235A>D42N>H233A; Km 
values for Mg2+ ranged from unchanged for H233A to 18- and 80-fold higher for H235A 
and D42N variants in comparison with the value for WT enzyme, respectively (77-79) . 
Similar results were observed for the corresponding DmpG variants, although removal of 
the aspartate ligand, rather than one of the histidines, appeared to have the most 
deleterious effect. In the case of two of the HMG-CoA lyase variants, direct metal 
binding experiments established that the variants were unable to bind metal ion in the 
absence of substrate. Although metal binding abilities of the DmpG variants were not 
measured in this study, the fact that they lacked metal ions after isolation suggests a 
similar conclusion. 
An arginine residue (Arg-17 of DmpG) is highly conserved in the active sites of 
HMGL-like family enzymes. Arg-41, the corresponding residue of human HMG-CoA 
lyase, has been studied in detail: the R41Q and R41M variants exhibited five and six 
orders of magnitude lower activity, respectively, relative to WT (70). This residue was 
proposed to stabilize the negatively-charged enolate intermediate during catalysis (<5). 
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The DmpG R17Q variant retained structural integrity based on fluorescence emission and 
far-UV CD spectra, and similar behavior as WT during purification. However, R17Q 
exhibited no detectable aldolase activity without added metal ion (Table 4.3) and three 
and half orders of magnitude lower activity with added either Mn2+ or Co2+ compared 
with WT (Tables 4.2 and 4.7). Thus, Arg-17 of DmpG, while not essential for catalysis, 
does contribute significantly to the rate enhancement by the enzyme as does Arg-47 in 
human HMG-CoA lyase. 
Based on the crystal structure, His-21 and Tyr-291 in DmpG have been proposed to 
be involved as general acid/bases in deprotonation of 4H2KV substrate, and protonation 
of the enolate form of the product pyruvate, respectively (4). DmpG variants H21A and 
H21Q showed no detectable aldolase activity without added metal ion (Table 4.3). With 
added Mn , aldolase activity of H21A or H21Q was three orders of magnitude lower 
than WT, while with Co2+, activity was 600-800 fold lower (Table 4.7). While it can be 
concluded that this residue is indeed important for catalysis, additional experiments are 
required to determine its role. In the case of Tyr-291, both variants, Y291A and Y291F, 
showed aldolase activity comparable to WT (Tables 4.2, 4.3 and 4.7), indicating that Tyr-
291 is not required for aldolase catalysis. 
In the crystal structure, Arg-17 and Tyr-291 of DmpG are involved in direct 
interaction with what appeared to be a product analogue, oxalate, that supplies two 
ligands for the active site metal ion. It is interesting to note that variants R17Q, Y291A 
and Y291F contain significantly less Fe and Mn than WT, while for His-21 and His-203 
which do not contact the active site metal ion or oxalate molecule, variants H21A, H21Q 
and H203A retain similar amounts of Fe as WT (Table 4.3). 
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A number of enzyme intermediate carbanions, including those associated with 
aldolases, have been reported to be reactive with external oxidants including oxygen 
(183, 184). The carbanions' accessibility to oxidants is a prerequisite for these reactions. 
Catalysis in HMGL-like family members has been proposed to involve formation of 
carbanionic intermediates (6) although no direct evidence has been reported previously 
and none was detected here using the external oxidant, tetranitromethane. This does not 
exclude the formation of carbanionic intermediate during the DmpG-catalyzed aldolase 
reaction, as the aldolase active site may be solvent-inaccessible during catalysis. 
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Chapter 5 Summary 
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DmpFG is bifunctional enzyme that is representative of numerous related 
enzymes involved in bacterial aromatic degradation pathways. Although the structure of 
the enzyme was determined previously, few functional studies have been done on it, or its 
close relatives. Studies of more distantly-related enzymes are useful, but of limited value 
in understanding how the two enzyme activities work together. 
Published work on DmpFG and related enzymes is summarized in Chapter 1. 
In Chapter 2, the coenzyme A (CoA) binding site of DmpF was delineated using 
H-D exchange, and supported by modelling studies, inhibition studies, and cofactor 
protection experiments. Although NAD+-and CoA-binding Rossmann folds have been 
described previously, this is the first time that a Rossmann fold designed to alternately 
bind NAD+ and CoA has been reported. The mode of CoA inhibition of DmpF, observed 
previously for other aldehyde dehydrogenases but not ascribed a cause, was shown to be 
consistent with disulfide bond formation between the thiol groups of Cys-132 and CoA. 
This conclusion was supported by results of DTT reactivation experiments, NAD+ 
protection assays, and modelling studies (Chapter 2), as well as site-directed mutagenesis 
evidence (Chapter 3). 
Chapter 3 extended the characterization of the DmpF active site to examine the 
role of a conserved putative active site cysteine residue, Cys-132. Cys-132 was 
previously proposed to be the essential cysteine of DmpF, and this was supported by the 
site-directed mutagenesis studies reported here. Mass spectrometry-based investigations 
detected formation of an acetyl-S-Cysl32 enzyme intermediate during turnover in either 
direction. Results were consistent with the separate observation of a ping-pong kinetic 
mechanism. In contrast to reported results of acetaldehyde-mediated inactivation of other 
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proteins, inactivation of DmpF by acetaldehyde was found to be correlated with apparent 
oxidation of Cys-132 to cysteine sulfmic acid by oxygen. In common with other 
aldehyde dehydrogenases, kinetic evidence was obtained indicating that the unhydrated 
form of acetaldehyde is a preferred DmpF substrate. Channelling of acetaldehyde from 
the active site of DmpG, where it is generated, to that of DmpF where it \s oxidized to the 
final product acetyl-CoA, as suggested by observation of a hydrophobic tunnel between 
the active sites, may protect acetaldehyde from hydration prior to entry to the DmpF 
active site. 
In Chapter 4, metal ion requirements, together with the involvement of proposed 
active site residues, were probed for the class II aldolase, DmpG: this enzyme is a recent 
member of the relatively poorly-studied HMGL-like family of enzymes. Although the 
tightly-bound metal ion in the DmpG active site appeared to be important for the overall 
stability of DmpFG, it only supported residual aldolase activity. Full activity required the 
presence of a weakly-bound stimulatory divalent cation. The notion that DmpG needs an 
extra metal ion for full activity was further supported by the observation that Zn is an 
uncompetitive inhibitor of the stimulatory divalent cation. A combination of ICP-MS and 
metal ligand mutagenesis demonstrated that metals in the DmpG active site comprise a 
mixture, with Fe and Mn predominating. According to previous data reported from our 
laboratory, the optimal stimulatory ions were Mn2+ and Co2+. The relative importance of 
residues Asp-18, His-200 and His-202 in metal ion binding were assessed using site-
directed mutagenesis, and site-directed mutagenesis also showed that Arg-17 and His-21 
are important for catalysis, but that Tyr-291 is not. 
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Future experiments are required to better delineate the roles of active site residues 
in the DmpG catalytic mechanism, and to provide experimental support for proposed 
channelling of acetaldehyde from the active site of DmpG to that of DmpF. This would 
involve more detailed kinetics of the DmpG active site variants, as well as site-directed 
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